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ABSTRACT 
Change in Serum Iron as a Measure of 
Bioavailability of Dietary Iron 
by 
Mary Beth Wright, Master of Science 
Utah State University, 1989 
Major Professor: Dr. Deloy G. Hendricks 
Department: Nutrition and Food Sciences 
ix 
Methods currently used to determine iron bioavailability have disadvantages for 
both the subjects and researchers involved. One safe and simple method that needs further 
evaluation, the serum iron absorption method, involves an initial blood drawing, dosage s 
of iron , and blood drawings taken at intervals thereafter . Generally, the rise in serum iron 
or area under the curve is used to determine iron uptake. Two experiments were conducted 
using the serum iron absorption method in an effort to improve the utility of this method for 
the measurement of iron bioavailability . With this effort in mind, an equation adjusting for 
dose of iron (0.5-8 mg) and blood volume was used to estimate serum iron absorption and 
allow for adequate comparisons of other iron absorption data obtained with this method and 
others . 
One very significant result was that low serum ferritin was found to be a predictor 
of high serum estimated iron absorption (SEIA). Similarly, low serum ferritin levels were 
also highly correlated to iron absorption when radioiron methods were used. 
In Experiment I, college-aged women (n=l 1) with low serum ferritin levels 
(average 11 ng/ml) participated in four serum iron trials in which four iron sources were 
used as iron dosages . Ferrous sulfate in orange juice (2.2 mg iron), ground beef (0.62 mg 
x 
iron), cereal (6.6 mg iron), and ground beef and cereal together (3.6 mg iron) were used. 
Comparisons were made between the results obtained using this serum iron absorption data 
and other radioiron absorption data for similar iron sources, and the results were quite 
similar to iron absorption levels reported in the literature. In Experiment I, the ferrous 
sulfate (40%) and ground beef treatments (46%) had the highest serum estimated iron 
absorption (SEIA) and the cereaVground beef (5%) and cereal treatments (3%) had 
significantly less. 
Experiment II involved 28 college-aged women who participated in four serum iron 
absorption trials . For these four trials the iron dose was the same (2 mg iron as ferrous 
sulfate in orange juice) . However, pre-trial supplements containing either (1) 30 mg iron, 
60 mg ascorbic acid, (2) 30 mg iron, no ascorbic acid, (3) no iron, 60 mg ascorbic acid, or 
(4) a placebo were given (one per day) on each of the three days prior to the weekly serum 
iron absorption trials. During each pre-trial supplementation period, three daily diet records 
were kept by subjects to determine if the previous intake of nutrients (from food or pre-trial 
supplements) influenced the outcome of the serum iron absorption trial. Pre-trial 
supplementation of 30 mg iron, no ascorbic acid caused a significantly lower SEIA. 
Dietary nutrients did not cause a significant effect on SEIA. Mean SEIA following 
combined iron supplements was lower (p=0.081) 16% vs . 23% following non-iron 
containing supplements. For this experiment, the SEIA was higher in subjects with low 
serum ferritin (<19 ng/ml) than in those with a high level (>20 ng/ml). 
(107 pages) 
IN1RODUCTION 
Iron deficiency is very common in both industrialized and developing countries, 
especially in children and women of childbearing age. Iron deficiency is quite prevalent in 
developing countries because of insufficient dietary iron. Due to this problem, it is 
important to learn as much as possible about how iron can be better utilized in the diet. 
There are many methods used to determine iron bioavailability, but each has its 
disadvantages; therefore, it seems pertinent to continue efforts to find an easy, cost- and 
;;-
time-efficient, safe method of determining absorption. Recognizing its disadvantages, .-
-
two experiments were conducted using the serum iron absorption method to predict iron 
bioavailability in humans. 
The purposes of this research were threefold. The first was to determine the 
validity of quantifying iron bioavailability using the serum iron absorption method. An 
effort was made to use this method accurately, safely and efficiently. The second purpose 
was to obtain data of iron bioavailability from red meat, fortified cereal, and a combination 
of the two. The third purpose was to determine if a three-day high intake of iron could 
~ -
~ock the absorption of iron in normal and iron-deplete women. If the iron intake does 
cause an iron block, it may prove to be a significant factor in understanding variations 
seen in earlier studies using this method. 
In this review of the literature, mechanisms of iron absorption, dietary factors that 
can influence it, and various methods used to determine absorption and iron status are 
discussed. 
2 
LITERA TIJRE REVIEW 
The Mechanism ofIron Absorption 
In contrast with other mineral elements, the regulation of body iron occurs at the 
level of absorption instead of excretion. The body has a limited ability to excrete iron; 
therefore , uptake by the intestine is restricted to a small percentage of the total body level 
(Linder and Munro, 1973). The mechanisms for controlling the uptake of iron in the 
intestines have been studied extensively; however, there are many unanswered questions . 
Currently the mechanisms of iron absorption are thought to occur in three steps: the 
passage of iron through the mucosal membrane, the role of iron compounds in transit 
through or storage in the mucosal cell, and passage through the serosal membrane and into 
the blood. 
Iron passa~e throu~h the mucosa! membrane 
Only a limited proportion (approximately 10%) of daily iron intake passes across 
the mucosa. The amount absorbed is determined by many factors, including exogenous 
(dietary) contituents, intestinal secretions, and endogenous mechanisms in the intestinal 
mucosa that respond to the body needs (Herbert, 1987). Conflicting data have been 
presented as to whether the process is passive or if it requires energy (Linder and Munro, 
1977). 
Intestinal secretions that might influence the solubility and absorbability of iron (by 
complexing with iron) in the GI tract include mucopolysaccharides, pancreatic juice, 
gastroferrin, and gastin. The solubility and absorbability of these complexes can be 
influenced by gastric acid output. This may be one reason it is so difficult to duplicate 
results in iron studies (Marx and Van den Beld, 1981). 
Endogenous factors that can influence the absorption of iron include the status of 
iron stores in the body and the rate of erythropoiesis. ~f the bod _ }}as de£reased iron 
stores, iron absorption increases, and vice versa. When erythropoiesis increases, the 
3 
absorption of iron increases (Peters et al., 1988). Increased erythropoiesis can be due to 
hypoxia at high altitudes, hemolysis, hemorrhage, mentrual losses, and fetal uptake. 
Decreases in erythropoiesis can be due to radiation treatment, hypertransfusions, and 
restoration of oxygen tension after a period of hypoxia or anemia (Linder and Munro, 
1977). 
Several studies have been conducted to determine the site where iron is absorbed in 
the small intestine. It was found that iron uptake by the proximal membrane vesicles of 
mice with normal iron stores was 3 to 4 times greater than from distal segments. In the 
iron-deficient mice, however, it was 10 times greater. There was no change in the distal 
segment uptake. This suggests that the regulatory changes in the proximal intestinal brush 
border membranes may account for the increased iron absorption known to occur in iron 
deficiency (Muir and Hopfer, 1985). / 
Transit throu~h or stora~ in the mucosa! cell 
Some investigators suggested that iron enters the cell as chelates of sorbitol, 
fructose, or ascorbic acid and that chelation is a necessary step. On the other hand, others 
found no evidence of a soluble iron-chelating molecule within the mucosal cell (Pyke and 
Brown, 1984). 
There are several major compounds identified in the mucosa! cytosol. These 
compounds are transferrin, ferritin, apoferritin, and a nonprotein molecule form or free iron 
salt. It is suggested that transferrin has a role in removing iron from the mucosa! cell 
(Linder and Munro, 1977). 
Ten percent of the iron in the mucosal cell is incorporated into the ferritin molecule. 
A distinctive property of ferritin is its capacity to bind and release iron while remaining 
intact. The roles of intestinal ferritin have been attributed to accommodating excess iron 
and to participating in the mechanism for regulating iron absorption (Munro and Drysdale, 
1970). In rats with marginal iron depletion, mucosal ferritin was found in higher amounts 
4 
in the iron-absorbing areas of the intestine, while newly absorbed radioactive iron 
incorporated into ferritin was found only in iron-absorbing areas, suggesting a role of 
ferritin in iron absorption (Johnson et al., 1983). 
Mucosa! iron not transferred to the portal blood is returned to the lumen of the 
intestines when the mucosa! cell is forced off the villus tip. Because iron can enter the 
mucosa! cells from the blood, the body can rid itself of some excess iron (Linder and 
Munro, 1977). 
Passa~e throu~h the serosal membrane 
Only the iron that penetrates the serosal membrane is absorbed; therefore, the 
serosal site has been postulated as the control area for iron absorption. How the transfer 
occurs and is controlled are still debated. Whatever the mechanism, iron must be released I 
from the membrane on the intracellular side and picked up on the other side of the cell for 
transport through extracellular fluid to the blood. Transferrin is believed to be the 
intracellular carrier in the iron absorption path through the cytosol partly due to its iron-
donating behavior (Huebers and Finch, 1984). 
Dietary Factors Influencin ~ Iron Absorption 
There are dietary factors that influence iron uptake that are an important 
consideration in an iron absorption study. These factors are referred to as enhancers or 
inhibitors. 
Factors that enhance iron absOJl?tion 
Heme vs, non-heme iron. Heme iron is comprised of ferrous or ferric iron in the 
center of a porphyrin ring. Non-heme iron includes iron-containing enzymes, ferritin in 
liver and other animal tissues, phosvitin-bound iron in egg yolk, phytoferritin in plant 
tissues, monoferric phytate, inorganic fortification irons, etc. (Pyke and Brown, 1984). 
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Heme iron is taken up by the mucosa! cells independently of non-heme iron as an 
iron-porphyrin complex, which is then split in the mucosa! cells by a specific enzyme. 
Non-heme iron and heme iron, then, seem to have a common pathway out of the mucosa! 
cells into plasma (Hallberg, 1981). 
Heme iron is absorbed much more readily than non-heme iron, and absorption is 
not enhanced or inhibited by dietary factors in the same way as non-heme iron. The only 
dietary factor thought to influence absorption of heme iron is the presence of meat (Morris, 
1983 ). It appears that the bioavailability of heme iron in meals containing meat is about 
25% and without meat is 10%, decreasing with increasing doses to a few percent 
(Hall berg, 1981). 
Ferric vs, ferrous state of iron. The retention of ferrous iron has been found to be 
greater than of ferric owing to a considerably higher mucosa! uptake (Marx and Van den 
Beld, 1981). Dietzfelbinger (1987) confirmed this phenomenon after examining 14 iron 
preparations using post-absorption serum-iron measurements. Geisser and Muller (1987) 
used the post-absorption serum-iron test with rats and confirmed a pharmacological 
difference between ferrous sulfate and a ferric preparation. They suggested that there may 
be a different absorption mechanism for the two valence states of iron. Forth and Schafer 
(1987) suggested that the iron bioavailability depends on the capacity of a preparation to 
prevent iron from formation of insoluble hydroxides and/or phosphates. 
Protein. Animal protein from meat, fish, and poultry has been found to enhance 
iron absorption, whereas protein from the egg, milk and plant sources do not affect iron 
absorption. Bemer and Miller (1985) proposed that the mechanism for this interaction can 
be explained by the nature of the protein digestion. For example, they hypothesized that 
the peptides released from the enhancing proteins are soluble, low-weight complexes that 
aid in delivering iron to the mucosa! cells, whereas the protein that does not enhance has 
decreased solubility. It is more commonly thought that the nature of the enhancement may 
be caused by the amino acids (especially the sulfur-containing amino acids). However, 
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because of conflicting results, others believe this is not the complete answer (Morris, 
1983). Hallberg (1981) suggested that the conflicting results may be related to the 
oxidation of cysteine into cystine caused by cooking heat. 
Ascorbic acid. It is known that ascorbic acid consistently enhances non-heme iron 
uptake whether it is a synthetic source of ascorbic acid or a natural part of the food. The 
reasons appear to be due to the ability of ascorbic acid to maintain iron in a reduced, more 
soluble form or to form soluble iron complexes (Hallberg et al., 1986). Morris (1983) 
found that a 1 :3 molar ratio of ascorbic acid to iron increased iron absorbance from infant 
foods at least sixfold. Hallberg et al. (1988) even hypothesized that ascorbic acid may be 
essential for iron absorption and may have a specific physiological role. Ascorbic acid has 
been reported to help overcome the effect of potent inhibitors of iron absorption such as 
phytates (Hallberg, 1981 ). In high-phytate foods, increased amounts of ascorbic acid are 
needed to counteract the inhibition. Hallberg concluded, after reviewing hundreds of iron 
absorption studies involving humans, that each main meal should preferably contain at 
least 25-50 mg of ascorbic acid and even more ascorbic acid if iron inhibitors are present 
(Hallberg et al., 1988). 
Or~anic acids. Gillooly et al. (1983) found that non-heme iron absorption from a 
rice meal was improved when citric, malic, and tartaric acid were present. In addition, 
vegetables containing these organic acids provided good iron bioavailability. 
Malic acid is found in deciduous fruits such as plums, peaches, and apples. 
Gillooly et al. (1983) found that malic acid can significantly enhance iron absorption. 
Tartaric acid is found in white wines and may play a part in the high bioavailability of the 
iron they contain. Though alcohol has been reported to be an enhancer of iron absorption, 
there is not total agreement on this issue. Other researchers have reported conflicting 
information on the effect of organic acids on iron absorption. 
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Factors that inhibit iron absorption 
Or~anic acids. Reinhold et al. (1986) found citric acid failed to promote iron 
bioavailability. They determined that it destabilized iron receptors and caused a release of 
iron previously retained. Sodium citrate blocked radioiron uptake completely in another 
study (Savin and Cook, 1978). 
Gillooly et al., (1983) studied how organic acids in vegetables effect iron 
absorption in the body. Oxalic acid caused some depression, and tannic acid and sodium 
phytate caused marked inhibition of iron absorption·. The vegetables that did not have 
good iron absorption had a high polyphenol content. 
Gordon and Chao (1984) challenged the Gillooly et al. (1983) conclusions on 
oxalic acid and determined that oxalic acid did not decrease the absorption or retention of 
radioactive iron in rats. It also has been reported that oxalic acid had no effect on iron 
absorption in humans (Hallberg, 1981). It may even exert a positive effect on absorption 
by keeping iron in the ferrous state, chelating it, or acting as a ligand( Gordon and Chao, 
1984). 
Tea, which is high in tannic acid, caused a decrease in the absorption of non-heme 
iron by 50%. Coffee was also inhibitory to a lesser extent, and iron absorption decreased 
by only 33%. Coffee has a high amount of polyphenolic compounds, which could 
influence iron absorption (Morris, 1983). Morck et al. (1983) determined that tea caused 
64% inhibition on iron absorption and coffee, 39% inhibition. It was thought that tea 
forms insoluble iron tannates. In any case, all soluble iron in both beverages was oxidized 
to the less soluble ferric form. Munoz et al. (1988) found that pregnant women who were 
coffee drinkers had lower hematocrit and hemoglobin at eight months gestation than the 
non-coffee drinking subjects. 
Although Gordon and Chao (1984) suggested that phytates may stimulate iron 
absorption, the effect of phytates is still being studied. When dephytinized grains were 
compared to those with a high level of phytates, the inhibition of iron absorption was not 
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changed. However, it is generally thought that phytic acid interferes with iron absorption, 
and foods with high levels tend to have poor iron bioavailability (Morris, 1983). 
Fiber. Fiber has been shown to be an inhibitor of iron absorption. Several studies 
have been conducted to determine what substituent of fiber causes this inhibition. Pectin 
did not decrease iron absorption in healthy or anemic dogs; neutral lignin decreased iron 
uptake in healthy dogs; cellulose had no effect, and psyllium mucilage decreased intestinal 
absorption of iron in both anemic and healthy dogs. The mechanism for this inhibition is 
uncertain; however, Fernandez and Phillips (1982) speculated that hydro-oxylic groups of 
lignin bind the iron. On the other hand, Gordon and Chao (1984) showed that lignin 
appears to have only a minor or no effect on iron absorption in rats. 
A phosphate fraction in the fiber is a constituent that may affect the iron absorption 
more than a certain type of fiber, especially when calcium and phosphate are both present 
(Hallberg, 1981 ). It is apparent that more research is needed to determine the exact cause 
of the inhibition of iron absorption by fiber. 
Soy products. A negative iron balance was seen in men eating a diet with 70% of 
the protein from soy. However, when ascorbic acid was added, the inhibiting effect was 
decreased (Morris, 1983). Beef added to a soy meal also provided an enhancing effect; 
however, it did not completely reverse the inhibiting effect (Morck et al., 1982). The 
general concensus is that soy products decrease relative bioavailability of non-heme iron 
(Morris, 1983). 
Calcium and phosphorus. In rats, inorganic iron absorption was decreased as 
dietary calcium was increased . In addition, liver iron concentration was decreased as 
dietary calcium was increased (Mahoney et al., 1985). The addition of phosphates to rat 
diets caused decreased iron absorption, decreased hemoglobin concentrations, and 
depressed liver iron values (Mahoney and Hendricks, 1978). Barton et al. (1983) showed 
that calcium significantly decreased the absorption of ferrous and ferric iron in a dose-
related manner in rats. 
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Methods Used to Measure Iron Abs01:ption 
The first method used to measure iron absorption was the chemical iron balance 
study. This technique is the only method that directly measures iron abso,rption from the 
whole diet. However, it is insensitive, imprecise and time consuming, and does not 
provide information on how iron absorption can be influenced by different meals 
(Hallberg, 1981 ). 
Reliable measurements of non-heme iron absorption were obtained after the 
introduction of radioiron. The radioiron method involves a measured quantity of radioiron 
given orally; then after several days, absorption is determined by measuring either the 
unabsorbed radioactivity found in fecal wastes or the radioactivity retained in the body. 
The iron retained in the body can be measured by determining the red cell radioactivity in 
blood drawn two weeks following the test dose or by whole body counting. However, 
whole body counting is limited to very few locations that have the necessary equipment. 
Measuring red cell radioactivity has possible errors caused by variations in the red cell 
incorporation of the absorbed radioactivity and in estimating total blood volume from 
surface area. These errors can be reduced by performing multiple tests on the same subject; 
however, this may not be safe for individuals (Cook, 1977). 
For determining iron absorption with radioiron, biosynthetic labeling of foods 
(intrinsic tag) was first considered the only valid approach to be used. Then the 
development of the extrinsic tag method was a major breakthrough . It involved mixing 
biosynthetically labeled foods with a trace amount of iron salt labeled with another 
radioiron isotope (extrinsic tag). The absorption from the extrinsic and intrinsic tracers 
was the same in each subject. Because of these findings and the studies that followed, the 
concept of a common non-heme iron pool was introduced, and dietary factors enhancing or 
inhibiting iron absorption could be studied more accurately (Hallberg, 1981). There are 
some iron sources with which the extrinsic tag does not exchange completely . These 
include insoluble forms of iron, such as contaminant iron, and large-particle reduced iron 
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such as ferric orthophosphate used for food fortification. Iron in purified ferritin, bran, 
and unmilled rice may only partially equilibrate with the extrinsic tag (Cook, 1977; 
Hallberg, 1981). 
Morris (1983) pointed out some of the disadvantages of using extrinsic radioiron in 
absorption studies. Radioiron is contraindicated for studies extending over several weeks, 
and the alternative use of stable isotopes becomes costly . Also, because of the small 
amount of iron absorbed, the metabolic balance may not be sensitive for all iron absorption 
studies . Another concern is the importance of preventing contamination of food and 
excreta analyzed . A frequent criticism of balance studies is the likelihood of incomplete 
excreta collection . It is difficult for subjects to collect stool samples for at least one week 
(Werner and Kaltwasser , 1987). 
Iron Absorption by Post-absorption Serum-iron Concentrations 
The iron tolerance test or serum post-absorpt ive curve was used in the 1940's to 
study iron absorption . Iron was ingested as a salt, usually ferrous sulfate , in 
pharmacologic dosages (50-250 mg or sometimes 1 mg/kg of body weight) , and then 
plasma iron concentration was measured at intervals . This method has been used to 
compare absorption of various therapeutic compounds and to demonstrate the ability of 
foods and medications to interfere with iron absorption (Crosby and O'Neil-Cutting , 
1984). 
An extensive review of this method was done by Josephs (1958). He suggested 
that there was not justification to promote these serum-iron curves as a measure of 
absorption unless at the same time the blood volume and rate of clearance from the plasma 
were also known. After reviewing the literature available from 1939-1958, Josephs ( 1958) 
provided the following opinions about this method: 
(1) The rise in serum iron is fairly rapid and a maximum level is reached in about 
two hours. 
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(2) The dosage of ferrous iron needed is about 4 mg/kg. 
(3) In the adult with blood loss resulting in hypochromic anemia, the rise in serum 
iron is more rapid, high levels are maintained longer and the return to normal is slower. 
However, there are exceptions in most studies. 
(4) In subjects with infection, the curve tends to be flatter and in many cases there 
is no rise. 
Those who were in favor of this method reasoned that absorption occurs only when 
iron is needed, and good absorption is seen when the post-absorptive curves are high. 
One inconsistency with this reasoning is that in essential iron-deficiency anemia, the curves 
are flatter than in cases due to chronic blood loss. If the _post-absorptive trials were 
repeated at short intervals, the first response was found to be higher than the subsequent 
ones. Josephs (1958) called this a temporary storage block. He also questioned the rate at 
which iron enters the plasma and indicated that the absorption may not be an immediate 
transfer. 
More recently, iron tolerance tests using small-iron doses have been used as an 
indicator of mild-iron deficiency. Crosby and O'Neil-Cutting (1984) used healthy young 
men with reduced iron stores due to phlebotomies. A dose of iron (5, 10, or 20 mg) as 
ferrous sulfate or ferrous fumarate was given. Blood samples were drawn before iron 
ingestion and subsequent samples obtained at various intervals thereafter. A peak in 
plasma concentration was usually attained about two to three hours after the iron dose was 
given. The rise in plasma iron concentration was significant and consistent in mildly iron-
deficient subjects. By using smaller doses of iron, the authors hypothesized that the 
sensitivity of this method seemed improved over the 1940's version of this method. 
Dietzfelbinger (1987) investigated the absorption of 14 commercial iron 
preparations by testing serum-iron concentration curves on healthy men. A therapeutic 
dose of 100 mg iron was used with ferrous sulfate as a control. They found a good 
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congruence with exact 59Fe whole-body retention tests and the post-absorption serum-iron 
concentration curves. Dietzfelbinger pointed out some of the criticisms of this method. 
There can be indeterminable factors such as invasion, distribution, and elimination of the 
iron after absorption, and where the iron goes cannot be followed precisely. He indicated 
that this procedure cannot be used for the quantitative estimation of iron absorption, but in 
looking at intraindividual comparisons of several iron preparations it can be very useful. 
Another worthwhile benefit is that the pos-tabsorption serum-iron concentration curves can 
be easily reproduced. 
This benefit was confirmed by Werner and Kaltwasser (1987). In a comparative 
study examining results derived from plasma-iron tolerance curves to both whole-body 
counting and plasma radioiron results, correlations of r=0.94 and r=0.91 were 
simultaneously obtained. In comparing maximal increases of serum-iron concentration to 
whole-body counting and measurements of radioiron in the plasma, correlation values of 
r=0.93 and r=0.96 were obtained. Kalwasser and Niechzial (1987) indicated that although 
the correlation of the area under the curve to radioiron absorption is high (r=0.97), it cannot 
always be used as a reliable prediction of absorption. 
On a smaller scale, Danisi et al. (1987) used serum-iron curves to successfully 
compare two different iron preparations. Iron-deficient subjects received a dosage level of 
80 mg of iron as either ferritin or iron-protein succinylate. The peak in the serum iron 
occurred at different times (4 and 2 hours, respectively) for the two preparations . 
However, both doses induced a significant increase in serum iron 30 minutes after 
administration. 
O'Neil-Cutting and Crosby (1987) used post-absorption plasma concentration to 
demonstrate a "mucosal-block" phenomenon. A blocking dose of 30 or (5() mg of iron was 
ingested 12 or 24 hours prior to the iron tolerance trial. Then a dose of 10 mg iron as 
ferrous sulfate was given to mildly iron-deficient subjects according to the usual procedure. 
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When 60 mg iron was used as the blocking dose, there was no increase in plasma iron 12 
hours later. If the dose was taken 24 hours prior to the tolerance test, the increase in 
plasma iron was 40% less than the control value. Results were similar for the 30 mg iron 
blocking dose. 
There are other methodology concerns to be considered in using the post-absorption 
iron curves as a measure of iron absorption. For example, there are plasma iron circadian 
variations in normal subjects over the 24-hour period. Some of this variation happens due 
to the return of iron liberated by the reticuloendothelial system from the hemoglobin of 
destroyed red cells and also due to dietary contribution (Najean et al., 1977). 
The other appropriate concern with this method is the effect of fever, infection, and 
inflammation on serum iron. Elin et al. (1977) investigated this effect by inducing fever in 
humans and confirmed a significant decrease in serum iron and a significant increase in 
serum ferritin. This change could last as long as 10 days. In studying patients with 
various infections in a hospital setting, Birgegard et al. (1978) confirmed these changes in 
ferritin and serum iron. The cause or type of infection (bacterial or viral) did not seem to 
influence these results. They provided suggestions to explain the phenomenon including 
decreased elimination or a shift in the intracellular ferritin balance. A decrease in serum 
iron was seen in rabbits infected with Pasterurella multocida as their rectal temperature rose 
(Kluger and Rothenburg, 1979). Kluger and Rothenburg (1979) hypothesized that fever 
provides a beneficial role by reducing the ability of pathogenic bacteria to grow well at 
elevated temperatures in an iron-poor medium. 
Iron Status 
Iron status is determined by biochemical procedures involving blood levels of 
serum ferritin, hematocrit, hemoglobin, serum iron, and iron binding capacity. 
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Serum ferritin 
Ferritin is the major storage protein for iron in the bcxly. Each ferritin molecule is 
composed of a spherical protein shell made up of 24 subunits with a variable amount of 
iron as a core of ferric-oxide-phosphate. Ferritin is a normal constituent of serum and 
circulating blood cells. The immunologic assay used to determine serum ferritin measures 
both iron-containing protein and apoferritin, but it gives no indication of the iron content of 
the molecule . Therefore, no assumptions should be made about the iron content of ferritin 
unless it is directly measured (Jacobs et al., 1975). 
The primary function of ferritin is to safely store iron in a readily accessible form 
for the synthesis of hemoglobin and iron-containing enzymes. It is also available to 
sequester potentially toxic insoluble iron in a soluble form (Halliday and Powell , 1988). 
This multifunctional molecule has other uses which include (1) storing and transporting 
iron and other metal ions, (2) functioning as a zinc and copper ion donor, (3) generating 
free radicals in the presence of a reductant, (4) functioning as a dephosphorylating agent, 
and (5) participating in regulation of myelopoiesis . A possible role in regulation of the 
immune system is currently being studied (Joshi and Zimmerman, 1988). 
Plasma ferritin concentration has little or no diurnal variation and remains relatively 
constant over a period of weeks . In groups with a high prevalence of anemia, the 
response of serum ferritin to iron supplementation is expected to be low and slow, just as 
~ he hemoglobin response is (Hallberg et al. , 1988). It is well accepted that the 
concentration of ferritin reflects total body iron stores in the absence of known complicating 
factors. Complicating factors that influence normal ferritin levels include liver disease, 
inflammation, infection, and some malignancies (Halliday and Powell, 1988). 
In normal subjects without these complications, iron absorption is inversely related 
to iron stores. This is well documented by the strong negative correlation shown between 
serum ferritin concentrations and iron absorption in subjects whose hemoglobin and serum 
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iron concentrations are normal (Jacobs et al., 1975; Baynes et al., 1987; Hurrell et al., 
1989). 
Normal ferritin values range from 10-200. Siimes et al. (1974) indicated that the 
clinical role of the serum ferritin assay parallels the size of iron stores and provides an 
excellent advantage in determining iron status in that low values are almost always 
diagnostic. Except in cases of anemia not due to iron deficiency, serum ferritin levels were 
elevated to a mean of 180 ng/ml (Lipschitz et al., 1974). 
Baynes et al. (1987) measured iron status in 853 women and found that 34.8% of 
this group had serum ferritin concentrations of less than 12 ng/ml. Cook et al. (1974) 
found the mean serum ferritin to be 34 ng/ml in 152 normal females. There was a 
significantly positive correlation between age and serum ferriti,11. 
Hematocrit and hemo~Iobin 
Hematocrit is the volume of packed red blood cells found in 100 ml of blood. 
Normal hematocrit levels range from 38-47% in females. The hemoglobin is a measure in 
grams of the hemoglobin per 100 ml of blood with normal values ranging from 12-16 g/dl . 
(Tilkian et al., 1979). 
Serum iron and iron bindin~ capacity 
Serum iron is used to diagnose iron deficiency. In this condition it will be low with 
an elevated iron binding capacity. Normal serum iron levels range from 50-150 ng/ml 
(Tilkian et al., 1979). 
Serum iron is decreased by the presence of fever and inflammation. Elin et al. 
( 1977) discussed the possible mechanism for this influence and suggested that fever may 
restrict the release of iron from red blood cells by the reticoloendothelial system. The same 
decrease in serum iron was seen in postoperative patients without infection. 
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MATERIALS AND METIIODS 
E"periment I 
Experiment I consisted of two parts, A and B. Part A was done as a preliminary 
rial of the serum-iron absorption method. Data were collected and analyzed prior to 
conducting Part B. Part B was done using this method with various food sources as the 
i-on dose, and subjects participating had low serum ferritin levels. 
"olunteer selection 
Through campus advertising, female volunteers were recruited. Young women 
tetween the ages of 18 and 30 were screened by the following criteria. They (1) were not 
ttlcing any type of drugs or medications, including iron supplements, (2) were not pregnant 
er lactating, (3) had body weight less than 130 pounds, and (4) were available in the 
norning hours. 
Permission was obtained through the Institutional Review Board for the Protection 
cf Human Subjects for this project. A consent form was signed by all subjects 
puticipating in this research (Appendix A). 
Part A. Volunteers were screened initially to test the serum-iron absorption method. 
Small doses of ferrous sulfate (.5, 1, 2, 3, or 4 mg) were administered in 120 ml orange 
juice following the same procedure outlined below (Table 4 in Appendix B contains 
individual data on each subject). Three skinfold measurements (left umbilicus, right 
s1bscapular and right triceps) were taken using calipers on the subjects between blood 
drawings to estimate percent body fat. Because these data did not highly correlate with 
SEIA in this experiment, it was not used for these experiments. 
Part B. After the Part A screening, an additional screening was conducted to find 
s1bjects with low ferritin levels who also fit the subject selection criteria listed above. 
Women who participated in Part A who had low ferritin levels were asked to participate in 
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Part B also. The women who consented to participate were instructed on the following 
serum-iron absorption procedure. 
Procedure for usin ~ the serum-
iron absorption method 
Each subject was asked to fast for 10 hours prior to participating in the serum-iron 
absorption trial . Subjects were weighed each day they participated in the trial . A trained 
medical technician drew two initial 3 ml blood samples (one heprinized) from each subject 
by venisuction . Then a small dose of iron was provided in one of four randomly assigned 
food items: 
dishes , 
(1) iron fortified cereal (6.6 mg iron), 
(2) cooked ground beef (.62 mg iron), 
(3) both ground beef (.3 mg iron) and cereal (3.3 mg iron), served in separate 
(4) ferrous sulfate in orange juice (2.2 mg iron) . 
Subjects were instructed to chew the food thoroughly and consume within two minutes. 
The food items were accompanied by 120 ml of tap water; however, no additional water 
except that contained in the orange juice was given for the ferrous sulfate/orange juice 
treatment. The cereal used was Life cold cereal , eaten without any preparation, the raw 
ground beef was microwaved for 0.5-1.0 minute on high , and the orange juice was frozen 
concentrate with two cans of water added instead of the usual three cans of water. 
Samples of blood (3 ml) were drawn 1, 1.5, and 2 hours after the consumption of 
the food item. Subjects were instructed to study or sit quietly between blood drawings 
during the serum-iron absorption trial. Ten subjects received all four treatments and one 
subject completed only the ferrous sulfate/orange juice and cereal treatments . An interval 
of one week (minimum) occurred between the four serum-iron absorption trials. 
Analysis of blood samples. Blood samples were analyzed at Logan Regional 
Hospital immediately following each trial for serum iron, unsaturated iron binding capacity, 
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total iron binding capacity, serum ferritin, hematocrit and a complete blood count. 
Serum iron levels and unsaturated iron binding capacity (UIBC) were determined 
using the American Monitor Blue 610 method. By adding the UIBC and serum iron, total 
iron-binding capacity was calculated. Serum ferritin was determined with a radioimmune 
assay kit manufactured by Becton/Dickinson. 
The Coulter S-Plus Counter, an automated hematology analyzer, was used to obtain 
the complete blood count (CBC) which routinely includes red blood cell count (RBC), 
hematocrit (Hct), hemoglobin (Hgb), mean corpuscular volume (MCV), mean corpuscular 
hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red cell 
distribution width (ROW), platelet count, and a differential count of the different types of 
leukocytes (i.e. neutrophils, eosinophils, basophils, and lymphocytes) . 
The RBC count included red blood cells 36 um and greater. The MCV was a 
parameter derived from the RBC population which included RBC between 36 and 360 um 
expressed in cubic micrometers. Hematocrit was obtained by the following equation: Hct 
(%) = RBC x MCV I 10. MCH was equal to 10 x Hgb I RBC and MCHC was equal to 
100 x Hgb I Hct. The RDW expressed the size distribution spread of the erythrocyte 
population. 
Using information obtained at each blood drawing, an estimate of serum-iron 
absorption was calculated according to the increase (or decrease) in total serum iron. 
Although actual intestinal iron absorption was not measured, this calculated value may 
prove adequate for estimation purposes. Because doses given were corrected for, data ( / 
:2. c / 
obtained using this method can be compared between subjects with different doses. The 
serum estimated iron absorption (SEIA) percentage was calculated as described below. 
Ecrnation used to calculate serum 
estimated iron absorption <SEIA) 
To calculate the SEIA for each subject, the following information was needed: 
current body weight (BW), a factor, 7% of BW, used to estimate blood volume (BV), 
19 
hematocrit (Hct), serum iron levels (S Fe), and the dose of iron that was provided to the 
subject. With this information the following equation was used: 
BV=BWx.07 
Serum Volume (SV) = BV x (100- Hct) 
Total Serum Iron (TSI) = SV x S Fe 
Gain in Serum Iron (OSI) = TSh - TSio 
SEIA =OSI/Iron dose x 100 
See Appendix C for an example of this calculation and the units of measure used. 
Values obtained by using this equation were referred to as SEIA. If the calculated 
values were obtained one hour after the dose was administered, it was designated SEIA(l 
h), or SEIA(l.5 h) for the 1.5 hour data, and SEIA(2 h) for the 2 hour data. For each 
subject, the highest calculated value for each trial, regardless of the time it was obtained 
was referred to as SEIA(max). 
Assays used to determine 
nutrients of treatment samples 
The beef used in this experiment was obtained from the USU Meat Laboratory of 
the Nutrition and Food Sciences Department. The ground-round beef came from a 
commercial grade animal specified as lean. 
The dipyridyl calorimetric method was used to determine iron levels, with a wet-
ash method for the fresh ground beef and a dry-ash method for the cereal (See Appendix 
D). The orange juice was analyzed using a wet-ash ferrozine method to determine the 
amount of iron it contributed (See Appendix E). The ground beef was analyzed for crude 
protein content using the Kjeldahl method (See Appendix F), and for crude fat using an 
ether extraction (See Appendix G). 
Statistical analysis 
Part A. The correlation was determined between blood parameters obtained and 
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SEIA(max). Subjects were separated into high and low ferritin groups and SEIA(max) 
percentages were compared. 
Part B. Four separate analysis of variance (ANOV A) models were used to compare 
treatment means for SEIA(l h), SEIA(l.5 h), SEIA(2 h), and SEIA(max). The statistical 
package used was Rummage. SEIA(max) percentages for the cereal, ground beef and 
ground beef/cereal treatments were compared relative to the ferrous sulfate/orange juice 
reference treatment for each subject 
Experiment II 
Volunteer selection 
Volunteers were recruited using the same approach as was used in Experiment I. 
An initial screening was done to determine the serum ferritin level of volunteers. All 
women screened were asked to participate, and the women who then consented were 
instructed on the serum-iron absorption procedure. An effort was made to obtain an equal 
number of women with low (less than 19 ng/ml) and high (greater than 20 ng/ml) ferritin 
levels. The subjects participating in the research were not informed of their serum ferritin 
status until after the experiment was completed. 
Procedure for usin~ the 
serum-iron absorption method 
Experimental desi~n inyolvin~ pre-trial supplementation. Using a nested design, 
each woman completed four treatments by taking one supplement per day, three days prior 
to the four iron absorption trials. These four pre-trial supplements consisted of: 
(1) high iron (30 mg), high ascorbic acid (60 mg), 
(2) high iron (30 mg), no ascorbic acid (0 mg), 
(3) no iron (0 mg), high ascorbic acid (60 mg), 
(4) no iron (0 mg), no ascorbic acid (0 mg) placebo. 
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The supplements were prepared fresh each week from ferrous sulfate, ascorbic 
acid, or sugar in gelatin capsules. Placebo doses were prepared with blue-colored 
granulated sugar replacing the ferrous sulfate and white powdered sugar replacing the 
ascorbic acid. Subjects were blind to the treatments given and knew only that they would 
receive vitamins and/or minerals in their supplements. 
The first supplement was randomly assigned and thereafter supplements were given 
in a specific order. For example, if a subject received treatment one first, it was followed 
the next week by two, three, and four; if number two were assigned first, it was followed 
by three, four and one; etc. The supplements were distributed so that seven subjects 
received supplement order 1,2,3,4; seven subjects received order 2,3,4, 1; six subjects 
received order 3,4,1,2; and eight subjects received order 4,1,2,3. This distribution was not 
equally divided among subjects because not all subjects assigned supplements participated. 
Supplements were given to subjects one week before the serum-iron absorption trial with 
instructions to take one capsule per day with water during the three days prior to each trial. 
Daily records of food intake. Subjects were instructed how to keep an accurate 
daily record of food intake, and forms were provided for each of the 3-day supplementation 
periods. A food frequency was completed to be used as a reference of the subject's typical 
eating patterns (Diet Intake Record and Food Frequency Forms in Appendix H). 
Nutrient information was determined for iron, ascorbic acid, fiber, calcium, 
phosphorus, folacin, energy, and protein from food eaten during the four 3-day 
supplementation periods. 
Data from the four 3-day dietary intake records were computer analyzed using The 
National Livestock and Meat Board Dietary Analysis and Food Comparison System. The 
food composition database for this computer program was compiled from the United States 
Department of Agriculture's: 
1) Primary Nutrient Data Set for USDA Nationwide Food Consumption Surveys 
(Release 1, 1986), 
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2) USDA Nutrient Database for Standard Reference (Release 6, 1987), and 
3) USDA Nationwide Food Consumption Survey Database (Release 2, 1986). 
Description of the serum-iron absorption method. For four consecutive weeks on 
either Thursday or Saturday, uniform serum-iron absorption trials were completed at the 
USU Student Health Center or the USU Nutrition and Food Science building. A 
minimum of one week interval occurred between trials. Each subject was asked to fast for 
10 hours prior to participating in the iron absorption trial. Subjects were weighed weekly 
on the day of the iron trial and skinfold measurements obtained during the last iron trial. 
Subjects each had an initial 3 ml blood sample drawn and then consumed ferrous sulfate 
(two mg iron) in orange juice each trial (similar to ferrous sulfate/orange juice dose for 
Experiment I). The second and third blood drawings were done one and two hours after 
the iron dose was given. Subjects (n=5)~ ho had a difficult time with the blood drawings 
due to small or hard-to-find veins had blood drawn only a second time after 1.5 hours. 
Analysis of blood samples. Hematocrit values were obtained immediately 
following the blood drawings. Other blood samples were centrifuged, and the serum 
frozen until all samples were analyzed at once for serum iron (see Appendix I), unbound 
iron binding capacity (see Appendix J), and ferritin (see Appendix K). 
EQuation used to calculate SEIA. The equation used to determine SEIA in 
Experiment I was used exactly the same way in Experiment II. 
Subjects' dates of menstrual cycle. Subjects provided dates of their menstrual cycle 
each time they participated in the iron absorption trial. The number of days since the 
subjects 'last menstrual cycle began was entered into the statistical regression analysis to 
determine its effect on SEIA. Because the experiment covered roughly one month, most 
girls had at least one menstrual cycle during the course of the study. 
Statistical analysis 
Using the Rummage statistical package, ANOV A and covariance were performed 
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on the blood parameters (serum ferritin, hematocrit, and serum iron) to compare levels of 
each order group and possible effects of the dietary nutrients and pre-trial supplements on 
these values. 
A correlation matrix among all variables was completed using a Minitab statistical 
package. ANOV A and analysis of covariance were completed to compare SEIA(l h), 
SEIA(2 h) and SEIA(max) means following each pre-trial supplement treatment. 
Covariates included in the statistical model were those that had statistical significance in the 
regression model. Serum iron and hematocrit values were never entered as covariates in 
ANOVA models with SEIA as the dependent variable because tl)ey were used in the 
equation to calculate SEIA. 
Separate ANOV A models (with 1.5-hour data put in as SEIA(l h), SEIA(2 h) or 
left completely out) were done to determine the most accurate way to use the 1.5-hour data. 
Then values for these subjects were included as SEIA(2 h) data because there were no 
differences with this data included or omitted. (There were differences noted with the 1.5-
hour data included as SEIA( 1 h) data). 
To look more closely at the influence of iron stores on SEIA, subject data were 
divided according to low (serum ferritin <19, n=18) and high (serum ferritin > 20, n=lO) 
ferritin groups and separate ANOV A was completed for each. SEIA(max) values were 
used in these analyses. Subjects with serum ferritin values close to 20 ng/ml were assigned 
into the high or low ferritin group, according to the mean serum ferritin value. The 
dividing point of 20 ng/ml was determined because most subjects (serum ferritin <19 
ng/ml) in Experiment I, Part A had fairly high SEIA. (In Experiment I, Part A, subjects 
with the lowest serum ferritin values (<9 ng/ml) had mean SEIA(max) of 55%, subjects 
with serum ferritin 10-19 ng/ml had mean SEIA of 23%, and subjects with serum ferritin 
>20 ng/ml had SEIA mean of only 11 %). 
To determine if combined SEIA results were influenced by the iron-containing pre-
trial supplements (iron/ascorbic acid; iron), these SEIA results were compared to those 
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obtained after the non-iron containing pre-trial supplements (ascorbic acid; placebo). In 
the same way, SEIA results following ascorbic acid-containing (iron/ascorbic acid; ascorbic 
acid) pre-trial supplements were grouped together and compared to those without ascorbic 
acid (iron; placebo). ANOV A statistics were also completed on these data using the 
SEIA(max) values. 
A stepwise regression to determine how variables (previous dietary nutrients, serum 
ferritin, and menstrual cycle dates) affected the SEIA was completed using dummy 
variables with the SPSSX statistical package. In this way, SEIA following the four pre-
trial supplements, order of supplements and order/supplement interactions were compared 
to the overall means, respectively. 
Nutritional content of food 
sources used as iron doses 
RESULTS 
Emmmentl 
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Cereal. The iron content of Life cereal was determined in our laboratory at 8 
mg/100 g. The USDA Handbook 8-8 (1982) value was higher at 26.4 mg/100 g. (See 
Appendix L for table 2 listing the nutrient content of Life Cereal). The label value ( 45% of 
the U.S. RDA) was calculated to be 29 mg/100 g. A serving of 25 grams of Life cereal 
was used (dose= 6.6 mg iron according to the published value which was used to do SEIA 
calculations). 
Ground beef. The iron content of the lean ground beef was determined in our 
laboratory to be 2.1 mg/100 g. The USDA Handbook 8-8 (1982) value for lean ground 
round similarly was 2.1 mg/100 g. The 29.4 g serving of ground beef provided an iron 
dose of 0.62 mg iron . The ground beef contained 23% crude protein and 2% crude fat 
(USDA Handbook 8-8 (1982) values, 21 % and 8%, respectively) . 
Ferrous sulfate/oran~e juice. The serving size of orange juice used in this 
experiment provided 0.2 mg iron I 120 ml if diluted (two cans water) concentrate. This 
was comparable to the USDA published value for concentrated orange juice. The ferrous 
sulfate/orange juice treatment provided 2.2 mg total iron which was used to calculate the 
SEIA values. The ascorbic acid level of the orange juice was not analyzed in our 
laboratory, but the USDA published value for ascorbic acid for this serving size of orange 
juice was 52 mg. 
Ground beef/cereal. The treatment of 14.7 g ground beef (0.3 g iron) and 12.5 g 
cereal (3.3 mg iron) provided 3.6 mg iron. 
Impact of serum ferritin on SEIA 
For both Part A and B of this experiment, a total of 43 women were screened, 53% 
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of whom (n=22) had serum ferritin levels less than 19 ng/ml, and 47% (n=lO) with ferritin 
levels greater than 20 ng/ml (ranging from undetectable to 80 ng/ml). 
In Part A of this experiment, the SEIA for the women with the low ferritin (<19 
ng/ml) averaged 39%, and those with high ferritin (>20 ng/ml) only 11 %. The quadratic 
correlation between SEIA and serum ferritin using only women with serum ferritin less 
than 20 ng/ml was r=-0.67. When all subjects were included, the quadratic correlation 
was r=-0 .79 (fig. 1). Because subjects with low serum ferritin had greater SEIA, an effort 
was made to include subjects with low serum ferritin levels for Part B of this experiment. 
Subject data 
Eleven women volunteered to participate in Part B of this experiment. Serum 
ferritin values ranged from undetectable to 39 with a mean of 11 ng/ml. Hematocrit values 
ranged from 37 to 46 with a mean of 41 percent. Their respective ages, heights and 
weights averaged 22 (range 19-31) years, 65 (range 61-68) inches, and 122 (range 110-
140) pounds . Table 6 in Appendix M provides individual data for each subject who 
participated in Experiment I, Part B. 
Effects on SEIA of dosin~ 
with food sources of iron 
Mean SEIA(max) was 46% for the ground beef, 40% for the ferrous sulfate/orange 
juice, 5% for the ground beef/cereal, and 3% for the cereal treatments. These SEIA(max) 
means are displayed in figure 2. 
The SEIA means for the ferrous sulfate/orange juice and ground beef treatments 
were significantly higher ( p< 0.001) than for the cereal and ground beef/cereal treatment 
means for the 1, 1.5, 2 hours, and maximal readings. See Appendix N for ANOV A 
results. Figure 3 represents the SEIA(max) for all subjects and the average SEIA for each 
treatment, illustrating the intra-subject variation. 
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estimated iron absorption when dosed with orange juice containing 0.5, 1, 2, 3, or 4 mg 
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SEIA(max) means for the ferrous sulfate/orange juice and ground beef iron treatments were 
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(p<0.001). 
75 
z 60 
0 '#-
a:~ 
- >< 
c <( 45 
w == 
.... -
<( z 
:!= Q 30 
-t-
ii 15illll I t 11 ~ I In II _ 
w 
en 0 
-15-t-~--r~,----~----,~-,---y---,---,e----,-~ 
1 2 3 4 5 6 7 8 9 1 0 11 AVE 
SUBJECT,# 
• Ground Beef 
II FeS04 
II Cereal 
ftJ Beef/Cereal 
Figure 3. SEIA(max) for each subject (n=l 1) according to subject number for the ground 
beef, ferrous sulfate/orange juice, cereal, and ground beef cereal treatments . Mean 
SEIA(max) values are also included. Experiment I, Part B. N 
00 
29 
By using ferrous sulfate as a reference relative to the other three iron sources, a 
comparison for each subject was made to correct for some of the intrasubject variation. 
The SEIA mean for the ground beef treatment relative to the ferrous sulfate/orange juice 
treatment was 104% vs. 8% for the cereal and 15% for the ground beef/cereal treatments. 
SEIA over time for all treatments 
To calculate area under the curve, more blocxl drawings would be needed over a 
longer period of time. For this experiment, data on the area under the curve were 
somewhat limited because only four blocxl drawings were done during a two-hour time 
period. Figure 4 illustrates how the ferrous sulfate/orange juice treatment SEIA means 
continued to increase during the two hours. The highest ground beef SEIA mean was at 
1.5 hours and was actually greater than the ferrous sulfate/orange juice SEIA mean (at 
1.5 hours); however, it decreased by 2 hours. The cereal and ground beef/cereal SEIA 
means changed very little during the two hour period. 
Experiment II 
Subject data 
College-aged women were screened for serum ferritin levels in this experiment. Of 
41 women screened, 20 (49%) had serum ferritin values <19, and 21 (51 %) had >20 
ng/ml. All women screened were invited to participate; however, only 28 completed this 
experiment, one of whom completed only two of the four serum-iron absorption trials. Of 
the 28 women participating, 10 had serum ferritin levels >20 and 18 had serum ferritin 
levels <19 ng/ml. 
Hematocrit values ranged from 36 to 47 with an average of 42%. Three subjects 
had low hematocrit values (36-37) and ferritin in the undetectable range for the duration of 
the study. 
The subjects' ages, heights, weights, and percent body fat respectively averaged 
22 (range 18-35) years, 66 (range 61-70) inches, 128 (range 99-167) pounds, and 16 
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Figure 4. SEIA means for ground beef, ferrous sulfate/orange juice, cereal, ground 
beef/cereal treatments for each blood drawing ( 1, 1.5, and 2 hours after the dose of iron 
was given). Experiment I, Part B. 
(range 12-24) %. Most subjects fit the subject selection criteria with weight less than 130 
pounds . However, taller women who were lean and slender participated, though their 
weight was above 130 pounds. Table 7 in Appendix O provides individual data for each 
subject for Experiment II. 
Dietary nutrient levels 
A complete computer analysis was completed on dietary intake records; however, 
only data on the nutrients known to influence iron absorption are reported (see table 1). 
The means provided below are the overall averages of the four 3-day food records. The 
ranges include the minimum and maximum 3-day averages. The ascorbic acid and iron 
contained in the pre-trial supplements were not included in the nutrient analysis 
Energy. The average (range) energy intake for all subjects was 1650 (800-2550) 
kcals. The lowest energy intakes were generally consumed on days that subjects had 
stomach flu. 
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Iron. The mean (range) iron intake was 12 (5-28) mg. The highest iron intakes 
were had by subjects who consumed two or more standard servings of 100% iron-fortified 
cereal. 
Ascorbic acid. The mean (range) ascorbic acid intake was 90 (0-300) mg. Several 
subjects did not consume fresh fruits and vegetables on a regular basis; however, others 
had up to 6 servings of orange juice in one day. 
Protein. Among the low ferritin group, two subjects were lacto-ovo vegetarians 
and others stated that they did not consume large quantities of meat due to cost, taste or 
convenience reasons. However, no dietary analysis was made on the source or quality of 
protein consumed. The average (range) protein intake was 60 (20-110) g which was 
slightly above the RDA of 54 g for a 60 kg woman (0.8 g/kg). 
Other nutrients. See table 1 for average intake levels of other nutrients. 
Table 1. Summary of the average (four 3-day food records) nutrient intake of subjects 
used in Experiment II. The ranges include the minimum and maximum 3-day averages. 
These values can be compared to the Recommended Dietary Allowance (RDA) . 
Nutrient Average Minimum Maximum RDA 
Energy (kcals) 1650 800 2550 
Iron (mg) 12 5 28 18 
Ascorbic acid (mg) 90 0 300 60 
Protein (g) 60 20 110 
Calcium (mg) 870 220 2220 800 
Phosphorus (mg) 1130 375 1960 800 
Vitamin A (IU) 6820 450 20800 4000 
Vitamin E (mg) 7 0 35 8 
Fiber (g) 14 4 31 
Folacin (mcg) 230 84 440 400 
32 
Correlation coefficients between dietazy nutrients. Correlations between nutrients 
were obtained to qualify the use of nutrients as covariates . (Two highly correlated nutrients 
were not concurrently used as covariates in the ANOV A). The following correlations were 
obtained: protein vs. energy, r=0.72; phosphorus vs. energy, r=0.73; calcium vs. energy, 
r=0.67; iron vs. vitamin E, r=0.64; phosphorus vs. calcium, r=0 .89; and phosphorus vs. 
protein, r=0.79 . 
Correlation of SEIA vs. dietazy nutrients. 
menstrual dates and serum ferritin 
Nutrients, both the day before trials (3rd day) and 3-day average, were correlated 
against SEIA(l h) and SEIA(2 h). Any nutrient that was highly correlated with SEIA(l h) 
or SEIA(2 h) is shown in table 2. The SEIA was positively correlated with vitamin A 
intake , both from the average intake values and from the day prior to the serum iron trial . 
No other nutrients had as significant or consistent correlations with SEIA. Dietary iron 
had a negative correlation; however, it was not significant. Ascorbic acid was not highly 
correlated with SEIA. 
Serum ferritin and the number of days since the last menstral cycle began were also 
correlated against SEIA(l h) and SEIA(2 h). Serum ferritin and SEIA had a high negative 
correlation (p<0.04) , just as in Experiment I. The menstrual cycle data did not 
significantly influence SEIA, nor was it highly correlated with any other variable except 
energy (p = 0.002). 
Pre-trial sup,plement effects on SEIA means 
Pre-trial supplement effects on SEIAO h). SEIA(l h) means following the four 
pre-trial supplements are displayed in figure 5. The SEIA mean following the iron/ascorbic 
acid supplement was 10%, 6% following the iron supplement, 18% following the 
ascorbic acid supplement, and16% following the placebo . These means were not 
significantly different (p = 0.225) and ferritin as a covariate had a significance level of 
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Table 2. Pearson correlation coefficients between SEIA(l h) and SEIA(2 h) and dietary 
nutrients (third day and 3-day mean values) and ferritin for Experiment II. Iron and 
ascorbic acid (not significant) and other nutrients that approached statistical significance are 
listed. 
SEIA(l h) SEIA(2 h) 
Fiber .0607 .1563 
3rd Day p=.268 p=.061 
Folacin -.1516 -.1043 
3rd Day p=.060 p=.152 
Vitamin A .1897 .2023 
3rd Day p=.026 p=.022 
Vitamin A .2702 
.24~ 
Mean p=.003 p=.007 _ 
--
Serum -.2592 -.1779 
Ferri tin p=.034 p=.005 
Iron -.0336 -.1030 
3rd Day p=.366 p=.155 
Ascorbic .0365 -.0889 
Acid p=.355 p= 191 
3rd Day 
p==0.073. The order in which pre-trial supplements were distributed was not a signficant 
influence on SEIA(l h) nor was there a significant order/supplement interaction. (ANOV A 
results are in Appendix P.) 
Figure 6 illustrates the differences among SEIA means following the four pre-trial 
supplement over time. Following the iron supplement, the means did not change from 
SEIA(l h) to SEIA(2 h) over time, as it did following pre-trial supplements with 
iron/ascorbic acid and the placebo. 
Pre-trial supplement effects on SEIAC2 h). SEIA(2 h) means (p=0.43) following 
the four pre-trial supplements are reported in figure 7. The mean SEIA following the 
iron/ascorbic acid supplement was 16%, 6% following iron, 17% following ascorbic acid, 
and 20% following placebo supplements. The highest standard deviation was noted 
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Figure 5. SEIA(l h) means (not significantly different) following pre-trial supplements 
(iron/ascorbic acid, iron, ascorbic acid, and placebo) for all subjects (n=28) for Experiment 
II. 
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Figure 6. SEIA means following all four pre-trial supplements (iron/ascorbic acid, iron, 
ascorbic acid, and placebo) for each blood drawing plotted over time for all subjects (n=28) 
who participated in Experiment Il. 
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Figure 7. SEIA(2 h) means following pre-trial supplements (iron/ascorbic acid, iron, 
ascorbic acid, and placebo) for all subjects (n=28) who participated in Experiment II. 
following the two pre-trial supplements that included iron. Serum ferritin was not 
significant as a covariate for the SEIA(2 h) readings. 
Pre-trial supplement effects on SEIA(max). The SEIA(max) means were similar to 
those of the SEIA(2 h) (fig. 8). Following the iron/ascorbic acid supplement, SEIA(max) 
was 19%, 12% following iron, 22% following ascorbic acid, and 24% following placebo 
supplements. Again, SEIA averages obtained following the four pre-trial supplements 
were not signficantly different (p>0.05). 
How the order pre-trial supplements 
were given in affected SEIA 
Using stepwise regression, the mean SEIA following the iron supplement was 
lower than the grand SEIA mean following all other pre-trial supplements (p<0.05). This 
could be due to the order in which the pre-trial supplements were distributed. For 
example, 75% of the subjects had the iron supplement immediately following the 
iron/ascorbic acid supplement, thus during six out of 14 days, iron supplements were 
administered. 
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Figure 8. SEIA(max) means following pre-trial supplements (iron/ascorbic acid, iron, 
ascorbic acid, and placebo) for all subjects (n=28) who participated in Experiment II. 
By chance, the pre-trial supplements were distributed with an unequal number of 
low ferritin subjects in order group 3,4,1,2 (mean 10 ng/ml), and with high serum ferritin 
(mean 24 ng/ml) in order group 4,1,2,3 . The SEIA mean for order group 3,4,1,2 was 
higher (31 %) than that (10%) for all other order groups (p=0.17). 
Effect of serum ferritin on SEIA 
following pre-trial supplementation 
A high negative correlation was seen with SEIA(l h) vs. serum ferritin (p=0.005). 
However, serum ferritin was not a significant covariate (p>0.05) with SEIA(2 h) or 
SEIA(max). Separate ANOVA was done for subjects with high (>20 ng/ml) and low (<19 
ng/ml) serum ferritin. For low ferritin subjects, significant differences occurred (p= 
0.082) between SEIA means (fig. 9). Following the iron/ascorbic acid supplement, 
SEIA(max) was 33%, 14% following iron, 46% following ascorbic acid, and 26% 
following placebo supplements. SEIA(max) means for high ferritin subjects were not 
significantly different (p= 0.543) following all pre-trial supplements as depicted in figure 
10. These SEIA means resemble what are expected, i.e. lowest SEIA after the 
iron/ascorbic acid supplement and highest SEIA after the placebo supplement. Following 
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Figure 9. SEIA(max) means following pre-trial supplements (iron/ascorbic acid, iron, 
ascorbic acid, and placebo) for the subjects with low ferritin levels. Significant differences 
occurred (p= 0.081) between SEIA means. Experiment II. 
60 
z 50 
~ -;fl. 
- ~ 
c >< 40 
w Cl: 
~~ 
;! ~ 30 
I- -en i-
w Q. 
:::& ~ 20 
:::, en 
a: CD m 1111: 10 
0 
FE/AA - FE/NO AA NO FE/AA NO FE/NO AA 
Figure 10. SEIA(max) means following pre-trial supplements (iron/ascorbic acid, iron, 
ascorbic acid, and placebo) for the subjects with high ferritin levels. Experiment II. 
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the iron/ascorbic acid supplement, SEIA(max) was 5%, 10% following iron, 10% 
following ascorbic acid, and 21 % following placebo supplements. 
Effect of iron supplements on SEIA 
The combined iron supplements (iron/ascorbic acid; iron) caused SEIA to be higher 
than the mean SEIA obtained after pre-trial supplements without iron (ascorbic acid; 
placebo). The data in figure 11 depict SEIA averages for these combined treatments for all 
subjects, high ferritin subjects, and low ferritin subjects. 
40 
z ~ o~ 30 FO-l a: 0 
-ox 
w <( 
I- == <( -
:E z 20 
-o I- -(/) I-
w c.. 
:E ~ 
::::, (/) 
10 a: CD 
w <( (/) 
0 
ALL SUBJ LOW FERR HIGH FERR 
Figure 11. SEIA(max) for all subjects (n=28), low ferritin (n=18) and high ferritin (n=lO) 
subjects following combined iron treatments vs. combined non-iron treatments. 
Experiment II. 
If all subjects were included in the statistical model, the SEIA mean after combined 
iron supplements (16%) was lower than the SEIA mean after combined non-iron 
supplements (23%). This difference between SEIA means approached significance (p= 
0.081). 
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For the high ferritin group, the SEIA mean following combined iron supplements 
(:4%) was similar (p=0.71) to the SEIA mean following the combined non-iron 
supplement (16%) . 
For the low ferritin group, mean SEIA after the iron supplements (18%) was lower 
tlan SEIA after combined non-iron supplement (28%). The difference between means was 
not statistically significant (p = 0.099). Serum ferritin, as a covariate, was significant for 
tl.e low ferritin group (p=0.032). When added to the ANOV A model for the high ferritin 
g:-oup or for all subjects, serum ferritin did not significantly influence SEIA . 
Effect of ascorbic acid supplements on SEIA 
The SEIA following the combined ascorbic acid supplements (iron/ascorbic acid; 
ascorbic acid) vs . SEIA following pre-trial supplements without ascorbic acid (iron ; 
p:acebo) are illustrated in figure 12 for high, low ferritin, and all subjects. 
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Figure 12. SEIA(max) for all subjects (n=28), low ferritin (n=18) and high ferritin (n=lO) 
subjects following combined ascorbic acid treatments vs. combined non-ascorbic acid 
treatments. Experiment II. 
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With all subjects included in the statistical model, combined ascorbic acid 
supplements did not influence SEIA mean (21 %) significantly as compared to the SEIA 
mean (18%) following non-ascorbic acid supplements. 
For the high ferri tin group, the SEIA mean following combined ascorbic acid 
supplements was 9% vs. 20% following the combined non-ascorbic acid supplements. 
This difference approached statistical significance (p= 0.069). 
For the low ferritin group, the SEIA following combined ascorbic acid supplements 
was 26% vs. 19% following the non-ascorbic acid supplements. This difference was not 
statistically significant (p=0.203). Serum ferritin was again a significant covariate in the 
ANOVA for the low ferritin group (p=0.041). 
Effect of pre-trial supplements and 
the order ~ven on blood parameters 
Subjects were randomly assigned pre-trial supplements in a specific order, without 
reference to ferritin levels. As indicated previously, the subjects in order 4,1,2,3 had a 
mean serum ferritin of 10 ng/ml and the order 3,4,1,2 had a mean serum ferritin of 24 
ng/ml . These contributed to a significant order/supplement interaction on weekly serum 
ferritin levels. However, the serum ferritin did not change consistently for all order 
groups during the course of the experiment. For example, mean serum ferritin increased 
for order group 1,2,3,4 from 12 at week one to 20 ng/ml at week four; however, for order 
group 4,1,2,3 it stayed the same and decreased for order group 3,4,1,2. Dietary iron (p = 
0.016) and protein (p = 0.045) were significant as covariates with serum ferritin. 
The intial serum iron levels obtained were not influenced by the pre-trial 
supplements or the order in which pre-trial supplements were given. Dietary iron levels 
from the foods eaten did not affect initial serum iron levels. Hematocrit was not influenced 
by pre-trial supplements or order of supplements, but dietary ascorbic acid was a 
significant covariate (p = 0.020) in the analysis. 
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DISCUSSION 
Experiment I 
Serum f erritin as a predictor of SEIA 
Serum ferritin vs. SEIA. Serum ferritin measurement is a useful_,convenient way to 
assess status of iron storage (Jacobs et al., 1975). Because people with low iron stores 
tend to absorb a higher percentage of iron, subjects with low serum ferritin should also 
increase the sensitivity of the serum-iron absorption test. This was confirmed in Part A and 
B of this experiment. For example, after dosing with ferrous sulfate, SEIA(max) was 
higher for the low ferritin subjects than for high ferritin subjects. The increased SEIA 
observed in the subjects with low ferritin was not associated with hematocrit, hemoglobin, 
or initial serum iron values. 
The results obtained in this experiment may differ from results obtained from 
subjects with iron-deficiency anemia; however, comparisons were made with other iron 
research using iron-deficient subjects. None of the subjects screened were anemic, but the 
low serum ferritin levels and high SEIA(max) indicate decreased iron storage. These 
results were similarly influenced by serum ferritin for our experiment and those by other 
researchers us_9ing different methods to determine iron bioavailability, as reported below. 
Serum ferritin vs. iron absorption; other methods. When methods other than serum 
iron absorption trials were used to determine iron absorption, low serum ferritin was a 
similar predictor of high iron absorption due to decreased iron stores. For example, 
Baynes et al. (1987) identified serum ferritin concentration to be the best predictor of the 
absorption of iron using radioisotopes. An inverse relationship existed between the 
absorption of radioactive ferrous ascorbate (3 mg iron) and the serum ferritin concentration. 
For subjects with serum ferritin levels less than 19 ng/ml, percent iron absorption means 
ranged between 40-70%, whereas the women with serum ferritin greater than 20 ng/ml, 
had percent iron absorption means between 10-35% (specific means not available). These 
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results were similar to SEIA means for the subjects using ferrous sulfate in Part A (mean 
39% SEIA) and Part B (mean 40% SEIA). 
Ward et al. (1977) used an immunoradiometric assay for rats and correlated serum 
ferritin with liver ferritin iron in the anemic, normal or iron-loaded rat. When rats on 
different diets were compared, there was not a significant correlation between serum ferritin 
and ferrous sulfate retention. However, when the rats were segregated by dietary regimen, 
mean intestinal absorption showed a significant inverse relationship to mean serum ferritin 
(r=-0.95). 
Cook et al. (1974) observed a similar significant inverse relationship between 
serum ferritin and iron absorption (r = -0.58 p <0.001) using a two-site immuno-
radiometric assay for humans. 
These examples were all very similar to SEIA results obtained in this experiment 
using the serum-iron absorption method. 
Hi~h serum ferritin. In this experiment, a subject with the highest serum ferritin 
level responded better to the serum-iron absorption test than subjects with serum ferritin at 
a more moderate level. For example, this subject (serum ferritin level of 80 ng/ml) had an 
unexpected high SEIA of 27%. Subjects with high serum ferritin levels may have a genetic 
predisposition for hemochromotosis, and always absorb the iron well, regardless of stored 
amounts of iron. 
Incidence of low serum ferritin levels in subjects. It was not difficult to find 
subjects with low serum ferritin levels for either experiment. For this experiment, subjects 
were informed that they were volunteering for iron research; therefore, women interested in 
anemia may have volunteered due to the nature of the research. Because of this possible 
bias, the distribution of serum ferritin for the women screened may not represent the typical 
population. 
However, the incidence of low ferritin subjects used in other studies was 
comparable to the number screened for this experiment. It has been suggested that a serum 
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ferritin of less than 12 ng/ml is taken as evidence of absent iron stores (Cook et al., 1974). 
In this experiment, 32% of the subjects screened had serum ferritin < 12 ng/ml. In 853 
Indian female volunteers, 34% had a serum ferritin concentration of less than 12 ng/ml 
(Baynes et al., 1987). Hercberg et al. (1985) found that of 107 women, 20% had serum 
ferritin levels of 12 ng/ml or less. 
Effects of usin& a low dose 
of iron for SEIA determinations 
Possible advanta~es of the low iron dose. One reason for using a small iron dose is 
that it can be better tolerated by subjects. For example, Hercberg et al. (1985) 
supplemented female subjects with 105 mg ferrous iron for one month and 35 of the 107 
women participating in the study stopped taking the supplements because of abdominal 
pains, diarrhea, nausea and/or vomiting, and constipation. 
Another reason for using a small dose is that the methods used to determine iron 
absorption that involve radioactivity usually consist of a standard meal containing a low 
dose of iron (2-5 mg). By using similar doses, the serum-iron absorption method can be 
better compared to results of these other human studies. 
The small dose provides a level of iron similar to that consumed in the diet. If 
100+ mg iron are needed to cause the serum-iron absorption curves to be accurate, then it 
becomes impractical for this method to be used with food iron sources. However, if the 
sensitivity of the small dose is adequate, then the potential for using this method to 
determine iron bioavailability increases. 
In this experiment, two subjects volunteered to participate in two additional serum-
iron absorption trials. In addition to the 2 mg iron dose, 4 mg and 8 mg iron were 
administered as ferrous sulfate in 120 ml orange juice. For both subjects, the 8 mg ferrous 
sulfate dose had the lowest SEIA (table 3). According to this limited example, it is possible 
that the high iron dose depressed the serum-iron absorption. The two mg iron dose used in 
Part B of this experiment was adequate to increase serum iron levels significantly for the 
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Table 3. Response to various levels (2.2, 4.2, and 8.2 mg) of ferrous sulfate by two 
subjects who participated in Experiment I, Part B. The maximum amount of iron absorbed 
in mg and the SEIA(max) values are included for both subjects. 
Subject#2 Subject #11 
Dose Iron Absorbed SEIA(max) Iron Absorbed SEIA(max) 
(mg) (mg) (%) (mg) (%) 
2.2 mg 1.6 71 1.2 53 
4.2mg 2.6 62 2.5 59 
8.2 mg 3.6 44 2.1 25 
ferrous sulfate/orange juice treatment. It is also interesting that the ground-beef iron dose 
was smaller and treatment SEIA means higher than for the ferrous sulfate/orange juice 
treatment. 
Because the low dose of iron was close to the subjects' requirement, it is possible 
for the entire dose to have been absorbed. Thus, iron absorption is not limited by a 
subjec~ need for iron. Humans are able to metabolize a small dose of iron, whereas a large 
dose cannot physiologically be handled by the body. 
Possible disadvanta~es of the low iron dose. For the traditional serum-iron 
absorption test, the therapeutic dose used is between 50 and 250 mg iron or 1 mg/kg of 
body weight. Recently Crosby and O'Neil-Cutting (1984) successfully tested this methcxi 
using small doses of iron (5-20 mg). The greatest rise in serum iron occurred with the 20 
mg dose. Lanzk:owsky et al. (1977) examined the dose response of the serum-iron 
absorption test on iron-deficient subjects with doses of 1, 2, and 5 mg/kg and also found 
the greatest magnitude of increase with the highest dose. However, without adjusting for 
the different dose levels administered one has difficulty interpreting or comparing the data 
Serum iron is expected to increase after iron dosing; however, in this experiment it 
was not always the case. For example, decreased serum iron levels resulting in negative 
percentages were seen for the cereal and ground beef/cereal treatments but not in the ferrous 
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sulfate/ferrous sulfate or ground beef treatments. Other researchers using high iron doses 
have not reported any decreases in serum iron; therefore, the low dose may be in part 
responsible for the negative percentages seen in this experiment Another factor to consider 
is the precision of the laboratory procedure used to determine the serum iron. The 
coefficient of variation was low (1.6 to 3.5% ). for the method used to determine serum 
iron in this experiment. However, for subjects with minimal increases in serum iron, the 
laboratory variation may cancel out the influence of the small iron dose (see detailed 
calculation taking into account variation for Experiment II on page 51 ). 
The hi~hest SEIA referred to as maximal SEIA 
The maximal SEIA may not necessarily indicate the highest peak the serum iron 
reached, but for comparison purposes it was useful. Most other researchers use the 
maximal serum iron peak, regardless of the time it occurred, as a reference point. A high 
correlation was obtained between the maximum rise in serum iron vs. whole-body counting 
(r = 0.93) and area under the curve vs. whole-body counting (r = 0.91) (Werner and 
Kaltwasser, 1987). 
For other studies in which the serum-iron absorption method was used, the time of 
blood draws ranged from zero to eight hours (Crosby and O'Neil-Cutting, 1984; 
Kaltwasser and Niechzial, 1987; Dietzfelbinger, 1987) or zero to six hours (Danisi et al., 
1987). In these studies, the maximal absorption reading for ferrous iron was usually 
reached by two hours after the dose was delivered. For other iron sources, such as dietary 
ferritin (Danisi et al., 1987), the maximal serum iron level was not reached until five hours 
after dosing. Crosby and O'Neil-Cutting (1984 page 1987) did "pilot studies using iron--
supplemented breakfast foods and autogenous blood drunk in tomato juice (10 mg iron) 
and the peak was later and lower than the corresponding test with ferrous sulfate." 
It is difficult to know if serum iron reached its highest peak during the two hours of 
this experiment. Ferrous sulfate has been reported to peak by two hours, but it is not 
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known if this time was appropriate for the ground beef, cereal and ground beef/cereal 
treatments. Three subjects (Part B) had an additional blood drawing three hours after the 
dose was given for the cereal and ground beef/cereal treatments. For four trials (two 
subjects) the SEIA(3 h) was higher compared to the SEIA(2h); the other subject (one trial) 
had a higher SEIA(2 h) level. 
Effect of usin2 the food 
sources as the iron dose on SEIA 
When the Life cereal was analyzed for iron content, an unknown error occurred; 
thus the Handbook 8-8 (1982) value for iron was used to calculate the SEIA percentages. 
Originally the experiment was designed to provide equal iron doses from each of the four 
treatments. This was not achieved (cereal 6.6 mg iron, ground beef 0.62 mg iron, ferrous 
sulfate 2.2 mg iron and ground beef/cereal 3.6 mg iron). 
Ferrous sulfate. It was not surprising that SEIA means were significantly higher 
with ferrous sulfate as the iron source than with cereal and ground beef/cereal. The ferrous 
sulfate dose did contain ascorbic acid which enhances iron absorption. The SEIA (39% for 
Part A low ferritin subjects and 40% for Part B low ferritin subjects) obtained using 
ferrous sulfate in this experiment was comparable to absorption values for ferrous sulfate 
treatments found in other studies. 
For example, it has been determined that non-anemic persons with no iron stores 
will absorb 40% of the standard reference dose (3 mg ferrous sulfate+ 30 mg ascorbic 
acid) (Morris, 1983). Park et al. (1983) used rats and found that the efficiency of 
converting dietary iron from ferrous sulfate varied from 60 to 84%, depending on the 
freshness of the source. The ferrous sulfate used illl this experiment was from a freshly 
opened bottle. 
Ground beef. The SEIA means were all positive for this treatment and the mean 
was significantly higher than the cereal and ground beef/cereal treatment means. The 
protein in red meat is an enhancer for both heme and non-heme iron (Morris, 1983). 
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The mean SEIA(max) for the ground beef treatment was 46%. This percentage 
was higher than that obtained from the ferrous sulfate treatment. The ground beef treatment 
SEIA relative to ferrous sulfate was 104%, which does not resemble data from most iron 
absorption studies. Possible reasons for this discrepancy include: (1) perhaps the smaller 
dose of iron administered in the ground beef caused a higher uptake by the serum iron than 
for the ferrous sulfate treatment; or (2) perhaps serum iron responds differently to heme 
iron vs. non-heme iron. These values are similar to iron absorption data for red meat 
using other bioavailability methods as reported below. 
Martinez-Torres and Layrisse (1971) used veal muscle with radioactively tagged 
iron and ferrous sulfate to determine iron absorption in humans. The mean iron absorption 
from veal iron was 21.5%, which was very close to that observed in the same subjects 
from iron ascorbate (23.8% ). Bjorn-Rasmussen et al. (1974) used the two-pool extrinsic 
tag method to measure heme and non-heme iron absorption from the whole diet. A high 
level of heme iron (37%) was absorbed vs. non-heme iron (5%) in men with normal iron 
stores. Cook and Monsen (1976) used the standard reference test meal to compare iron 
absorption in humans from different meat sources. There was a wide variation in iron 
absorption ranging from 0.6 to 56.0%. All of these studies used subjects with both 
normal and deficient iron stores. 
Layrisse et al. (1968) provided 4 mg iron from radiotagged veal to iron-deficient 
subjects and normal subjects and obtained iron absorption levels of 27% (iron-deficient) 
and 20% (normal). Layrisse et al. (1969) reported that mean iron absorption from 
hemoglobin was 7% (range 0-16) for normal subjects and 12% (range 6-21) for iron-
deficient subjects. In their study, the absorption of veal iron (range 2.5-19.7%) was 
significantly higher than all other foods and appeared to exceed even the absorption of 
ferrous ascorbate (ratio 1.31 ). 
Cereal. The SEIA(max) mean for the cereal treatment was 3.4%. This cereal iron 
dose caused the lowest SEIA and provided no enhancers. It did contain fiber, a known 
48 
inhibitor of iron absorption. The cereal treatment SEIA was 7.8% relative to the ferrous 
sulfate treatment. These results were not uncharacteristic of results obtained from using 
other iron absorption methods. 
For example, Cook and Monsen (1976) indicated the normal absorption of single-
food items tagged with radioiron shows that absorption from cereal foods is usually less 
than 5%. Hurrell, et al. (1989) reported that the mean iron absorption from infant cereal 
ranged from 4.28 to 1.68% for humans without iron deficiency. 
Layrisse et al. (1969) reported radioactive iron absorption from wheat ranged from 
1.7-7.9%. Cook et al. (1973) reported that healthy subjects absorbed 0.3% iron from 
fortified bread when sodium iron pyrophosphate was the source, 1.1 % with ferric 
orthophosphate and 8.6% with a reduced iron source. 
Ground beef/cereal. The SEIA(max) for the ground beef/cereal treatment was 
4.9%. More subjects had negative SEIA for this treatment than for other treatments. In 
comparing the SEIA for this treatment to the ferrous sulfate, the relative percentage was 
15%. This percentage was improved over the cereal treatment alone, however, not 
significantly. This improvement may be due to the enhancement effect of the meat. If this 
is the case, the enhancement was not as high in comparison to results from other radioiron 
studies. 
For example, Bjorn-Rasmussen and Hallberg (1979) conducted a study to 
determine the effect of animal proteins on the absorption of maize iron in man. When 
amino acids were added to maize porridge, a slight but statistically significant increase in 
iron absorption occurred (from 3.6% to 5.0%). Martinez-Torres et al. (1974) found the 
absorption of liver iron was significantly lower when it was administered with maize (13%) 
than when it was given alone (20% ). However, the absorption of maize iron was 
significantly higher when it was administered with liver (7%) than when it was given alone 
(2%). 
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Drop in serum iron due to stress. There was increased subject variation from this 
treatment as evidenced by the negative SEIA. In subject #6, the serum iron dropped 
sharply. She did, however, have a final exam immediately following the iron trial and was 
unusually stressed as she studied between blood drawings. The stress of infections is 
known to influence serum iron levels; however, there is no information available on the 
effect of other stressful situations. Josephs (1958) discussed a possible role of emotional 
factors in iron absorption studies, " ... postabsorptive curves tended to be lower in patients 
on days of conflict and indecision than on days of good spirits." He postulated that this 
may be due to an effect of gastrointestinal motility or secretions. If there is a 
stress/absorption interaction, it could possibly account for some of the intrasubject variation 
evident when using all methods of iron absorption determinations (Josephs, 1958, p. 34). 
Experiment II 
Variation in the serum iron assay 
The serum iron determinations for Experiment Il were done as outlined in Appendix 
I. According to the instruction pamphlet, the coefficient of variation for four different 
pooled serum preparations (assayed on eight occasions) ranged from 5.5% to 9.6% for the 
serum iron assay. (The variation for this assay was higher than the assay for Experiment 
I.) Because of the high variation, this particular procedure probably was not precise 
enough for the sensitivity needed with low iron doses. The laboratory variation could 
explain the negative absorption values and could indicate a lower or higher magnitude of 
change than the serum iron values showed. For instance, to illustrate this situation, a 
subject with serum iron values of 104 ng/ml initially and 99 ng/ml an hour later (Dose= 2 
mg ferrous sulfate, Hct 44% and weight 44 kg) would have · a SEIA(l h) of -4%. If the 
highest variation (9.6%) was in effect for this example, the serum iron could actually fall 
within a range of 94-114 ng/ml for the initial reading and 90-108 ng/ml for the second. 
Because these ranges actually overlap, it is possible the serum iron level did not change. 
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The SEIA values could have ranged from -22% to 12% if the most extreme initial serum 
iron reading had been actually 94 ng/ml and the second, 108 ng/ml. 
The dose given in this experiment was probably too small for the amount of 
variation possible with this particular laboratory procedure. If the same example were 
applied using a 4.2 mg dose of iron, the most extreme difference in serum iron values 
would have caused the SEIA to range from from -11 % to 7%. In addition to narrowing 
the range of SEIA, the serum iron would be expected to increase accordingly. 
Although the serum-iron absorption trial had limitations in terms of the precision 
and subject variation, it correlated well with other methods incorporating radioiron when 
used simultaneously (Kaltwasser and Niechzial, 1987). 
Rise in serum iron. The rise in serum iron that occurred after a small dose of iron 
did not reach the same magnitude as it did following a high iron dose. In the low ferritin 
subjects used in Experiment I, the mean rise in serum iron at two hours was 32 ng/ml for 
the ferrous sulfate treatment and 35 ng/ml for low ferritin subjects from Experiment II 
following the placebo supplement (29 ng/ml with all subjects included). In the study 
conducted by Crosby and O'Neil-Cutting (1984), the mean serum iron increased at two 
hours for iron-deficient subjects were 54, 80, and 110 ng/ml for iron doses of 5, 10, and 
20 mg respectively. The magnitude of change in serum iron was not enhanced greatly by 
using pharmacological doses. For example, iron-deficient subjects given an 80 mg dose of 
iron protein succinylate had a mean serum iron increase of only 49 ng/ml (Danisi et al., 
1987). These examples indicate that the serum iron levels do increase in response to dose 
to a certain extent; then, at some unknown point, saturation occurs. 
Problems with the nested 
supplement assi~ment desi~n 
It is possible that the level of SEIA may have been dependent on how frequently the 
iron supplements were consumed. The iron supplement was the only treatment that caused 
SEIA to decrease significantly (p< 0.05). The pre-trial supplements were distributed with 
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the iron supplement following the iron/ascorbic acid supplement for 75% of the subjects, 
which could have caused a cumulative iron effect and possibly influenced SEIA more than 
either treatment alone. 
It is known that low ferritin subjects absorb higher levels of iron than subjects with 
adequate iron stores. Though the first pre-trial supplements were randomly assigned, the 
order subjects received supplements formed a grouping of subjects according to the order. 
By chance, order group 3,4,1,2 had more high ferritin subjects and 4,1,2,3 had more low 
ferritin subjects. Consequently, the order group with low serum ferritin had the highest 
SEIA. In general, the order in which treatments were given did not significantly (p>0.05) 
affect SEIA(l h), SEIA(2 h) or SEIA(max). 
Effects on SEIA of nutrients consumed 
12rior to serum-iron abs011>tion trials 
The nutrients from dietary food sources did not influence SEIA. In the ANOV A 
models, nutrients consumed in the diet were not significant (p>0.05) as covariates, and 
none were entered in the stepwise regression model. 
Dietary protein and iron significantly influenced serum ferritin levels in this study. 
Serum ferritin is known to increase with iron supplementation. Hercberg et al. (1985) 
found after one month, subjects with a daily dose of 105 mg of ferrous iron had a mean 
serum ferritin increase from 24 to 41 ng/ml . 
The reason for the dietary ascorbic acid relationship to hematocrit is not understood. 
Hallberg et al. (1988) questioned the effect of ascorbic acid as being a nutritional factor 
essential for the absorption of iron in man. 
Vitamin A intake was highly correlated with SEIA. The mechanism for this is not 
completely understood, but the relationship between anemia and vitamin A has been 
examined in both rats and humans. For example, Hodges et al. (1978) first examined the 
vitamin Nanemia phenomenum in humans. After consuming a vitamin A deficient diet, 
five subjects developed anemia, though iron (18 mg/day) was adequate in their diet. Blood 
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was taken weekly which would add to the occurrence of anemia, but the anemia was still 
not corrected when even higher levels of dietary iron were added. After the vitamin A 
repletion was started, a rise in hemoglobin occurred with a prompt and complete 
hematological recovery. In another study on Central American children, plasma retinol 
and serum iron were positively correlated (Majia et al., 1977). Staab et al. (1984) used rats 
to support the hypothesis that vitamin A is involved in the regulation of iron released from 
the liver. However, they found that low dietary iron affected hematocrit and hemoglobin, 
but low vitamin A did not 
Effect of menstrual cycle on SEIA 
The number of days since the last menstrual cycle began did not influence the 
SEIA. This is not surprising because the information does not provide any indication as to 
the quantity of blood losses nor the length of the cycle. Therefore, it cannot be concluded 
from these data that the menstrual cycle does or does not influence the serum iron trial. 
Menstrual cycle and energy had a significant positive correlation; however, this may 
merely indicate that amounts of food consumed vary during the the menstrual cycle. 
Hie:h standard eviation 
There was a large amount of variation among subjects using this method, just as 
there has been when other methods were used for determining iron absorption . 
Unfortunately, the variation is high enough to cancel out any significant differences 
between SEIA means . SEIA between treatments was not significant; however, certain 
SEIA trends would be expected. 
How previous day's iron and ascorbic 
acid supplements affected SEIA 
How the previous intake of iron affects iron absorption has been investigated using 
radioiron in both rats and humans. Fairweather-Tait and Wright ( 1984) used rats with 
normal iron stores to test the results when a low (8 ug iron/g BW) or high (566 ug iron/g 
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BW) iron diet was given three days prior to a whole-body iron-retention test. In this 
experiment, mean proportion of iron retained was higher from the low-iron dosed rats. 
When a range of iron levels from 8 to 1,270 ug iron/g BW was given, again the proportion 
of iron retention was higher with the low dose. There was no significant difference in iron 
retention when the iron doses were given only one or two days before the test instead of 
three days. Apparently only one meal during the previous 24 hours was required to 
influence the mucosal block phenomenon. Fairweather-Tait et al. (1985) continued this 
research by testing how soon the iron meal must be given to make a difference in the test 
absorption. There was a significant reduction in iron absorption for groups given a high or 
medium iron meal at 12, 24, 36, and 48 hours before the test meal, but not at 60 hours. 
Finally, Fairweather-Tait and Minski (1986) used normal human subjects to test iron 
absorption using the fecal-balance technique. The 50 mg iron load (as ferrous sulfate) 
given 18 hours before the 59Fe-labelled ferrous sulfate significantly reduced iron 
absorption 35% to 29% the following day. 
O'Neil-Cutting and Crosby (1987) demonstrated the same type of phenomenon 
with serum-iron absorption testing. The dose of 30 or 60 mg of iron as ferrous sulfate 
was ingested 12 or 24 hours prior to the iron trial of 10 mg of iron. Both doses diminished 
absorption of the 10 mg iron dose for the trial. When the interval was 24 hours, serum 
iron increased more than when the interval was 12 hours. This was not similar to findings 
seen with the serum-iron absorption experiment. 
In this experiment, SEIA(l h) and SEIA(2 h) following the iron supplement are as 
noted previously, significantly lower than following the other supplements' grand mean. 
The possible cumulative effect of six iron supplements in two weeks causing the depressed 
SEIA does not compare to the rat data (Fairweather-Tait and Wright, 1984). There was no 
significant difference when the iron meals were given a total of one, two, or three days 
prior to the iron absorption. 
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The subjects in the high ferritin group had SEIA as expected, with the highest SEIA 
after receiving the placebo and the lowest after the iron/ascorbic acid treatment. Overall, the 
low ferritin group did have higher SEIA following all supplements; however, the SEIA 
following combined ascorbic acid supplements was higher than those without ascorbic 
acid. 
The combined iron supplements caused the SEIA(max) to be as expected according 
to the mucosa! block theory. In this case, SEIA following the combined iron supplements 
was lower than SEIA following supplements without iron. The low ferritin group was the 
most affected by the intake of the previous day's supplemented iron; however, the overall 
SEIA mean was still higher than for the high ferritin group. It is possible that the 
supplements taken prior to the serum-iron absorption trial blocked the absorption of trial 
dose to some extent, but low iron stores were still the determining factor. 
Ascorbic acid influenced the low ferritin group differently than the high ferritin 
group. The high ferritin group SEIA mean following the combined ascorbic acid 
supplements was lower than for supplements without ascorbic acid. The low ferritin group 
followed the opposite trend and to a lesser magnitude. The reasons for this are not known. 
However, if ascorbic acid were included in the diet of high ferritin subjects, perhaps 
enough iron would be absorbed to meet their needs. It is possible that the acidic medium 
provided by ascorbic acid in the GI tract is critical for the low ferritin group to be able to 
absorb the iron. 
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CONCLUSIONS 
Results obtained in these experiments using the serum-iron absorption methcxl were 
very similar to results obtained using other methods involving radioactive iron. Low serum 
ferritin was the best predictor of a high SEIA, which was similar to results of iron 
absorption determined using other methcxls. This serum-ferritin effect on subjects was 
consistent in both Experiments I and II. 
The SEIA data from Experiment I related well to published iron absorption values 
using other methods. For the ferrous sulfate/orange juice, cereal and groundbeef/cereal 
treatments data were very similar. The ground beef treatment results were similar to a few 
published values, but more research is needed to determine the cause for this. 
In Experiment II, the data compared well with the published data on the effect of 
an iron-blocking dose. The only discrepancy was that the iron pre-trial supplement had 
more of a blocking effect than the iron/ascorbic acid pre-trial supplement. The pre-trial 
supplement with iron alone caused the lowest SEIA; however, this could be related to the 
order in which the supplements were given. Also, combined iron treatments were lower 
than treatments without iron, as would be expected according to other literature. 
Experiment II provided interesting trends in the effects of combined ascorbic acid \ 
and combined iron treatments on high and low ferritin subjects. Overall, the low ferritin 
subjects had higher SEIA levels than did the high ferritin subjects. There was a trend for / 
the low ferritin subjects to have lower SEIA after the iron treatments and higher SEIA after 
the ascorbic acid treatments. The high ferritin subjects were not as affected by iron 
treatments; however, the SEIA was lower after the ascorbic acid treatments. 
The use of the equation to calculate SEIA provided a benefit over using the rise in 
serum iron only. Correcting for the dose consumed allowed for comparisons among 
doses. One complaint about the method is that it is dose-responsive and is thus often 
misinterpreted. 
56 
In an effort to decrease some of the intrasubject variation, this researcher offers 
suggestions for selecting subjects for a serum iron trial. It is important to choose subjects 
with low ferritin and, because ferritin values increase with age, choosing subjects close to 
the same age may be important. Subjects taking iron supplements regularly would not be 
appropriate. Previous day's dietary intake did not seem to influence the SEIA; thus, no 
consideration need be made in this area. 
LIMITATIONS AND 
SUGGESTIONS FOR FUTURE RESEARCH 
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1. To use the serum iron absorption method adequately, one should select an assay for the 
determination of serum iron that will have low laboratory variation. This becomes even 
more critical if a low dose of iron is used. 
2. The time the serum iron level actually peaks needs further exploration. It is not known 
if the size of dose could influence the time the maximal SEIA occurs. 
3. If a blood sample becomes hemolyzed, the serum iron value could be increased to a 
level beyond that which the small dose of iron provides. 
4. The benefit of using the equation to calculate SEIA is that adjustments to dosage can be 
made . If this type of calculation is not used, comparisons between doses cannot be made, 
thus decreasing the utility of the method. 
5. Care must be taken to obtain an accurate quantification of the dose to be delivered at the 
iron absorption trial. Increased research is needed using food sources that supply the iron 
dose. 
6. Due to the unknown effect of stress on the results of the serum iron trial, this factor 
should be considered in future research. 
7. The level of SEIA in relation to the amount of iron lost in the menstrual cycle could be 
explored in more detail to determine if it significantly influences the SEIA levels. 
8. Subjects with depleted iron stores, as measured by low serum ferritin, are the best 
choice for enhanced SEIA and decreased variation. 
9. More research is needed to determine if the percent body fat can be used as a correction 
factor when the equation is used to calculate blood volume. 
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Waiver and Release Consent Fonn 
65 
WAIVER Af .. JD RELEASE 
As a precondition of the University's acceptance of my application to participate in 
an Iron E.'.:oavailab ility study as conducted by Or. Oe!oy Hendricks and graduate asst. 
H ary Beth Wri9ht (in which I understand I will have 3 cc of blood dr·awn twice --
one hour apart,) and wi 11 divulge cer·tain personal data , I am hereby waiving any 
clair.1 to loss, liability, damage, or injury whatsoever arising out of or relating to 
my engaging in this activity . I hereby release and discharge Utah State University 
and its ager:ts and employees from any clairn. liability. loss. darnage. or injury of any 
natUt·e made by me or· others on my behalf to third persons. 
Signature 
r·~ame (printed) -----------------
,A.ddress --------------------
[1ate 
w" ['.Jote: This is a legally binding document. Please consult with your a:torne y if 
you have questions about its effect . 
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Appendix B 
Experiment I. Part A: Individual Subject Data 
Table 4. Summary of results for each subject including individual information on iron 
dose, serum ferritin (Ferr), hematocrit (Hct), serum iron levels (S Fe), and SEIA values 
from Experiment I, Part A. 
Subject# S Fe S Fe SEIA Ferr Dose Hct 
(0) (1) 
1 92 138 60 3.7 2 37.5 
2 49 68 56 3.7 1 38.0 
3 118 148 70 4.3 1 40.0 
4 33 81 59 4.9 2 37.7 
5 63 95 60 4.9 4 36.1 
6 95 151 66 5.3 2 40.3 
7 50 123 57 5.5 3 37.1 
8 80 114 39 5.7 2 43.5 
9 106 148 46 7.2 2 41.1 
10 125 220 53 7.8 4 34.8 
11 43 53 - 7 8.2 2 40.0 
12 73 99 29 9.6 2 40 .9 
13 68 94 71 9.7 2 40.0 
14 72 106 22 11.1 2 42.3 
15 80 109 34 11.7 2 42.0 
16 60 78 25 13.2 2 40.5 
17 63 95 30 13.3 2 39.7 
18 114 115 1 15.8 3 40.3 
19 113 148 37 16.0 2 42.3 
20 157 161 33 16.0 0.5 42.3 
21 85 97 6 16.1 4 39.1 
22 84 106 38 19.3 - 2 44.2 
23 88 94 1 20.3 4 43.2 
24 102 116 45 22.1 1 41.8 
25 148 158 6 24.8 3 38.4 
26 152 126 -14 32.0 4 39.2 
27 81 94 7 34.6 4 43.1 
28 53 81 17 34.7 2 44.8 
29 119 122 2 49.4 1 40.0 
30 99 96 -1 69.4 3 37.7 
31 100 95 -2 70.2 4 44.3 
32 128 158 27 79.9 2 40.4 
Ap_pendix C 
Serum Estimated Iron Absorption Sample Calculation 
Variables needed to perfonn the calculation: 
a) Body weight in kilograms (BW) 
b) Hematocrit level (Hct) 
c) Serum iron levels (S Fe) 
d) Dose of iron delivered (Fe) 
e) Estimation for blood volume percentage (.07) 
Sample Calculation: 
1) First estimate the amount of serum in liters by calculating: 
55 kg BW x .07 (% blood in the body) = .60% blood volume (BV) 
.60 (BV) x (1.00 - Hct .40) = 2.31 liter of serum. 
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2) Next determine the mcg of gain in serum iron for each blood drawing in relation to 
the initial blood drawing. For example, if the initial S Feo = 54 mcg/100 ml and 
one hour S Fe1 = 70 mcg/100 ml, then calculate: 
70 S Fe1 - 54 S Feo = 16 mcg/100 ml S Fe Gain. 
16 mcg/100 ml S Fe Gain x 2.31 liters x 10 d1/l = 370 mcg S Fe gain 
3) Last, calculate percent Serum Estimated Iron Absorption (SEIA) by adjusting for 
the dose of iron delivered. For example, if a 4 mg dose of iron sulfate were given, 
then calculate: 
370 mcg S Fe gain/4000 mcg Fe dose = 9.2% SEIA(l h) 
Rea~ents 
(a) 
(b) 
(c) 
(d) 
Determination 
Iron Detennination. Calorimetric Method 
Alpha, alpha-dipyridyl solution (0.1 g a, a-dipyridyl dissolved in water, 
then dilutedto equal 100 ml). 
Iron standard solution (1000 ppm) 
Hydroxlyamine Hydrochloride solution (50 g H2NOH.HC1 dissolved 
in water, then diluted to 500 ml). 
Sodium acetate solution (2M) (272 g NaOAc.3 H20 dissolved in 
water, then diluted to 1 liter). 
(1) Pi pet 10 ml digested sample solution into a 25 ml volumetric flask. 
(2) Add 1 ml hydroxylamine hydrochloride solution and let it stand. 
(3) Add 9.5 ml 2 M sodium acetate solution (pH 4-5). 
(4) Add 2 ml of the a,a-dipyridyl solution, dilute to volume with distilled 
water and let it stand for 5 minutes. 
(5) Determine absorbance at 510 nm. 
(6) Plot standard curve using iron concentration (Y) against OD (X). 
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Appendix E
Ferrozine Assay for Iron Detennination 
Rea~ents 
(a) Iron Standard Solution: 1 mg Fe/ml 
(b) Ascorbic Acid: 0.02% in 0.2 N HCl (0.02 g of ascorbic acid+ 1.65 ml 
concentrated HCl + water to 100 ml). Prepare daily and keep refrigerated. 
(c) Ammonium Acetate: 10% solution used as a buffer 
(d) Ferrozine Reagent: 1 mM in ultrapure water. This reagent is light-sensitive 
and should be kept in the dark and refrigerated. (0.0510 g ferrozine 
reagent+ water to equal 100 ml) 
(e) o-nitrophenol: 0.1 % solution . 
(f) Sodium Hydroxide: 12.5 N NaOH for a buffer solution to adjust pH to 
between 6 and 7. 
Procedure 
(1) In test tubes place 1, 2, 3, 4, 5, 10, 20, etc . mcl of 0.1 gram standard iron 
solution. Blank is 0.5 ml of water. 
(2) Place 0.1-0.25 mcl of ashed sample (dissolved into concentrated HCl 
to 2 ml). Adjust pH to 5.5 by adding 12.5 N NaOH. 
(3) Add 1 drop of 0.1 % o-nitrophenol solution (colorless below pH 5.5, 
yellow above. Add water to 0.5 ml. 
(4) To reduce all iron to the ferrous state, add 1.25 ml 0.02% ascorbic acid 
in 0.2 N HCI. Mix and let stand for 15 minutes. 
(5) Add buffer solution, 1.0 ml 10% ammonium acetate. Mix well. It is 
important for the solution to have a pH of close to 5.5. Adjust the 
pH with concentrated base or acid. 
(6) Add 1.25 ml of the Ferrozine color reagent. Mix well. 
(7) Add water to total volume of 5.0 ml and let stand 45 minutes. 
(8) Read absorbance at 562 nm. Plot standard curve. 
(9) If the solution is opaque, the samples must be centrifuged. 
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Ai>peodix F 
Micro Kjeldahl Method For Protein Detennination 
Di~estion 
1) Grind or homogenize the samples. 
2) Weigh 0.1 - 0.5 g sample into digestion tubes. 
3) Add I piece of Tecalor Special Kjeltabs S3.5 (3.5 g K2S04, 0.0035 g Se) 
to each tube as a salt/catalyst. 
4) Add 10 ml H2S04. 
5) Put samples into preheated digestion unit and gently heat for half an hour, 
then increase temperature to about 420 degrees C and heat until solution is 
colorless or pale yellow. 
6) Cool and dilute samples by adding 65 ml of deionized water. Place flask in 
ice bath to cool before distilling. 
Determination 
Analyze the digested sample for nitrogen using a Tecator Kjeltec Auto 1030 
Analyzer according to the procedure outlined in the instruction manual for the Auto 1030 
analyzer . 
(1) Connect the tube to the 1030 Analyzer. 
(2) Close the safety door. 
(3) Distillation, titration and calculations are performed automatically by the 
Auto I 030 Analyzer. 
Calculation of Crude Protein 
Calculate nitrogen content: 
Nitrogen(%)= ml HCl x Normal of HCl x 14 fUNormal x 100 
1000 ml/1 x sample weight (g) 
Crude protein content was calculated from nitrogen content by multiplying by the 
nitrogen factor of 6.25. 
Reference: Kjeldahl Procedure for Kjeltec Auto Systems 1030. 
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Ap_pendix G 
Detennination ofCrude Fat 
Procedure 
1) Weigh a clean, dry fat dish for each sample and store it in the desiccator. 
2) Weigh 0.5 - 2 g well mixed sample into a Majonnier extraction flask. 
3) Add 8 ml distilled water to each flask and mix. 
4) Add 1.5 ml of ammonia and mix in the small bulb of the flask. 
5) Add 10 ml of 95% ethyl alcohol, insert the cork and shake thoroughly. 
6) Add 25 ml of ethyl ether and shake for 20 seconds. 
7) Add 25 ml of petroleum ether and shake for 20 seconds. 
8) Place the extraction flask in the holder of the centrifuge and tum the handle 30 
turns taking about 30 seconds. 
9) Carefully pour off the ether solution into a previously dried and cooled fat dish. 
10) Repeat the extraction a second time adding in tum 5 ml alcohol, 15 ml ethyl 
ether and 15 ml petroleum ether, shaking for 20 seconds after each addition. 
Centrifuge again for 30 turns. Pour off the ether solution into the same fat 
dish used for the first extraction. 
11) Evaporate the ether in fat dishes by placing them on the hotplate under the 
hood. 
12) After the ether is evaporated, place the dish in the vacuum oven at 135 degrees 
C and dry for 5 minutes under a vacuum of not less than 22 inches of 
mercury. 
13) Transfer the dish to the cooling desiccator and allow to cool for 7 minutes 
with the power unit running. 
14) The dish and fat are weighed and the weight of the fat determined by 
subtracting the weight of the dish. 
15) Subtract the value of the blank and calculate the mean percent fat. 
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Appendix H 
Diet Intake Record and Food Freguency Forms 
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DIET RECORD FORM 
!NSTRUCTlrn--JS: 
1. List the foods you eat, including the name and amount for three consecutive ciays 
prior to the scheduled tt-ial. (For example, if you come for your iron tr:al on 
Fridays, record intake tor Tuesday, Wednesday & Thursday.) Please try to eat your 
typical foods and amounts . 
2. F:ecord EVERYTHING you eat or dri:ik in each 24 hew· per ;od. Remember to 
wr ite do·wn such items as coffee, tea, cream, sugar, juice, m ilk, butter , margarine, 
jelly, gr·avy, mayonna ise, ketchup, mustar·d, pickles, soft dr·inks, alcohoi, etc.) 1 
3. Descr ibe how the food wa,- prepared and eaten (e.g., bciled, fr ied, baked, etc. ) ar:d 
give a brand name when possible. If a cassero ie or combinat ion di~h is eaten, please 
include the recipe and indicate what port ion of the dish you consumed. (Set e:, amp ie 
be!ov .r.) 
4. Reco,·d the amount of each food and beve1·age in tern, ~ of units :,ucr as cup(~), 
ounce(s), tabiespoon(s), teaspoon(:;), or sl ice(s). 
5. Record the time you took your suppler;-1ent and what you took ,t with (e.g. water, 
m i ik , etc .). 
3-0AY INTAKE RECORD 
DATE: __________ _ 
T!tv1E FOOD TYPE FOOD 
WAS E/;TEN WI DESCF:IPTIO~J 
HOW FOOD 
WAS PREPARED 
At-v1our\JT 
CONSUt'-1EO 
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EXP.J-1PLE: 
Tli-,1E FOOD TYPE Fnnn H11\A1 Fr1nr1 
WAS PREPARED WAS EATEr-~ W/ OESCRIPTIOf,J 
8:00 a.m. -whole wheat bread to,:lS ted 
on toast 
12:30 p.m. 
3:0C p.rn. 
6:00 p.rn. 
-mar-garine, tub 
-milk , whole 
-Carnpbel Is tomato 
soup 
-crackers, saltine 
- cheddar cheese 
-apple juice 
-took supplement 
made w/ whole 
low-sodium variety 
melted in s:oup 
canned Tree-Top 
-spaghett i sauce made sirnmer-ed 
with: 
1 lb r1amburgei-(lean) 
2 6 - oz cans tomato paste 
1 /2 tsp gar Ii c powder· 
l pkg gener·ic ~earnning~ 
.Afv1r. 1, lt\JT 
crn~sur--1Eo 
2 slices 
2 tsp 
12 oz. 
1.5 cups 
7 crackers 
1/2 cup 
2 cup:; 
3/ 4 cup rn- 1 / 6 
tota: rec!pe 
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-spaghetti noodles boiled w/salt 8 rna,g 1.5 cup cooked 
-green beans, canned boiled 
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FOOD FREQUENCY 
1. Do you take a vitamin/mineral supplement? ______ _ 
If so, what brand do you take'='-------------
How do you usually take it? (i.e . with milk, water, coffee, tea or juice) 
How nvmy time; per-week do you t.::ike it? ________ _ 
2. Do you drink tea or coffee? 
---- ------
If so, when do you typically drink it? ____________ _ 
How rnany cups do you typically drink per-day? ________ _ 
3. Have y:::,u eve:· had any unusual cravings for things othe;· thc:n foDd stuff (i.e. dirt, 
cla1, starch, ice)? If so, please expiain : 
-------
4. [io you eat at re9u!ar time:, each day? _____________ _ 
5 . Hov ... · many days a week do you eat: 
a morning meal? _______ _ 
a lunch Or" mid-day meal') ________ _ 
an evening meai? ____________ _ 
during the evening or night? ________ _ 
6. How many times a week do you usually eat away from home? _____ _ 
What place~ do you eat at? ____________________ _ 
7. Would you say your· appetite is good? ___ _ fair'; 
-----
poor? 
----
77 
8. How many times per week do you eat the following foods? (whether at meals or 
bet\..Jeen rnea Is) 
luncheon meat 
hot do,Js 
I iver· 
poultry 
por·k or han-1 
n-:e~t in rn i:<ed dishes 
beef or veal 
other meat 
peanut butter or nuts 
rni lk 
cheese or cheese dishes 
yog1.ir-t 
i cf: cream, pucld i ngs 
cust.,rd, er-earn ~;oup 
citn1s fruit 
fruit juice 
other" fruit 
dr·ied frnit 
raw vegetables 
salad, lettuce type 
cooked vegetables 
green leafy vegetables 
cold cereal 
cooked cereal 
pancakes Or" viaff les 
b<:1gels, r-nuff ins, breaij 
tortillas, pita b(ead 
crackers 
0 1 2 3 4 5 6 7 )7 
0 1 2 3 4 5 5 7 >7 
0 1 2 3 4 5 6 7 )7 
012345f,7 )7 
0 1 2 3 4 5 6 7 )7 
0 1 2 3 4 5 6 7 >7 
0 1 2 3 4 5 6 7 >7 
0 1 2 3 4 5 6 7 >7 
0 1 2 3 4 5 5 7 )7 
0 1 2 3 4 5 6 7 >7 
0 1 2 3 4 5 6 7 )7 
0 1 2 3 4 5 6 7 >7 
0 1 2 3 4 5 6 7 )-, I 
0 1 2 3 4 5 6 7 >7 
0 1 2 3 4 5 6 7 ' .., / I 
0 1 2 3 4 5 6 7 >7 
01234:,67 )7 
0 1 2 3 4 5 6 7 >7 
0 1 2 3 4 5 6 7 )7 
0 1 2 3 4 5 6 7 >7 
0 1 2 3 4 5 6 7 >7 
Q 1 2 3 4 5 6 7 )7 
0 1 2 3 4 5 6 7 )7 
0 1 2 3 4 ~' 6 7 >7 
-----
0 1 2 3 4 5 5 7 )7 -----
01234567 . )7 
-----
0 1 2 3 4 5 6 7 >7 
-----
0 1 2 3 4 5 6 7 >7 
-----
0 1 2 3 4 5 6 7 )7 
-----
0 1 Z 3 4 5 6 7 >7 
-----
0 1 2 3 4 5 6 7 )7 
-----
0 1 2 3 4 5 6 7 >7 
-----
macar"oni, spa~1hetti, 
rice, noodles 
butter, margar·ine 
salad dr-essings, spr-eads 
0 1 2 3 4 5 6 7 >7 
-----
0 1 2 3 4 5 6 7 >7 -----
O i 2 3 4 5 6 7 >7 
-----
9. What specific kind~~ of the following foods do you eat most often? 
fruit juic:E-s _______________________ _ 
vegetabies _______________________ _ 
rn-:at _________________________ _ 
ffli lk 
-------------------------~ 
cold cereal _______________________ _ 
cookecl cer"ea I
------------------------
A:apendix I 
Detennination ofTotal Serum Iron 
Rea~ents 
(A) Iron Buffer Reagent: Contains Hydroxylamine Hydrochloride, 1.5%, in 
Acetate Buffer, pH 4.5 
(B) Iron Color Reagent: Contains Ferrozine, 0.85%, in Hydroxylamine 
Hydrochloride solution. 
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(C) Iron Standards: Contain iron, 50, 100, 200, 300, and 400 mcg/100 ml, in 
Hydroxylamine Hydrochloride solution. 
Manual Procedures 
(1) Label test tubes BLANK, STANDARD, SAMPLE 1, etc . 
(2) To each test tube add 2.5 ml Iron Buffer Reagent. 
(3) To BLANK, add .5 ml iron-free water . To each STANDARD, add .5 ml 
iron standard . To each SAMPLE add .5 ml serum . 
(4) Mix each test tube well. Read Absorbance (A) of SAMPLE and 
ST AND ARD vs. BLANK as reference at 560 nm. This is INTI1AL A. 
(5) To each test tube add .05 ml Iron Color Reagent and mix well. Place in 
water bath at 37 degrees C for 10 minutes. 
(6) Read and record Absorbance of SAMPLE and STANDARD vs. BLANK as 
reference at 560 nm. This is FINAL A. 
Calculations 
Serum Total Iron (mcg/100 ml)= 
FINAL ATest- INITIAL ATest 
FINAL AStandard - INITIAL AStandard 
Reference 
Sigma Technical Bulletin No. 565. 
80 
Appendix J
Determination of Serum Unsaturated 
Iron-Bindin~ Capacity 
Rea~ents 
(A) UIBC Buffer Reagent: Contains Tris (Hydroxymethyl) Aminomethane, 0.5 
mol/liter, pH 8.1. 
(B) Iron Color Reagent: Contains Ferrozine, 0.85%, in Hydroxylamine 
Hydrochloride solution. 
(C) Iron Standards: Contain iron, 50, 100, 200, 300,and 400 mcg/100 ml, in 
Hydroxylamine Hydrochloride solution. 
Manual Procedures 
(1) Label test tubes BLANK, STANDARD, SAMPLE 1, etc. 
(2) To each test tube add 2.0 ml UBIC Buffer Reagent. 
(3) To BLANK, add 1.0 ml iron-free water. To each STANDARD, add .5 ml 
iron-free water and .5 ml Iron Standard. To each SAMPLE add .5 ml 
serum and .5 ml Iron Standard . 
(4) Mix each test tube well . Read Absorbance (A) of SAMPLE and 
ST AND ARD vs. BLANK as reference at 560 nm. This is INITIAL A. 
(5) To each test tube add .05 ml Iron Color Reagent and mix well. Place in 
water bath at 37 degrees C for 10 minutes. 
(6) Read and record Absorbance of SAMPLE and STANDARD vs. BLANK as 
reference at 560 nm. This is FINAL A. 
Calculations 
Serum Unsaturated Iron-Binding Capacity (mcg/100 ml)= 
FINAL A Test - INITIAL A Test 
500-
FINAL AStandard - INITIAL AStandard 
Reference 
Sigma Technical Bulletin No. 565. 
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Ap_pendix K 
Detennination fSerum Ferritin 
Rea~ents 
(a) Fem.tin Antiserum. Lyophilized fem.tin antiserum reconstituted by adding 
10 ml distilled water. 
(b) [ 1251] Fem.tin. Iodinated fem tin, ready to use. 
(c) Fem.tin Calibrators. Fem.tin calibrators in a protein base containing 0, 10, 
25, 100, 200, 500, and 1000 nanograms of fem.tin per milliliter. 
(d) Precipitating Solution. Precipitating solution contains goat anti-rabbit 
gamma globulin and dilute polyethylene glycol in saline. Ready to use. 
Specimen Collection 
The patient does not need to be fasting, and no special preparations are necessary. 
Collect blood into plain tubes, avoiding hemolysis and then separate the serum or plasma 
from the cells. The procedure calls for 100 mcl of serum per assay tube. The samples may 
be stored under refrigeration for seven days . Samples may be stored frozen for longer 
periods of time, however, avoid freeze-thaw cycles. Prior to assay, allow the samples to 
come to room temperature and mix by gentle swirling. 
Raclioimmunoassay Procedure 
(1) Label tubes in duplicate : T (total counts), NSB (nonspecific binding), A 
(maximum binding) and B-G. Label additional tubes, also in duplicate for 
serum samples and controls. 
(2) Pipet 100 mcl of the zero calibrator A into the NSB and A tubes, and 100 
mcl of each of the remaining calibrators B-G into correspondingly labeled 
tubes. Pipet 100 mcl of each patient sample (serum or plasma) and each 
control into the tubes prepared. 
(3) Add 100 mcl of [1251] Fem.tin to all tubes. 
(4) Add 100 mcl of Fem.tin Antiserum to all tubes except the NSB and T tubes. 
Vortex. 
(5) Incubate for 1 hour at 37 degrees C. 
( 6) Add 1.0 ml of well-mixed cold precipitating solution to all tubes. Vortex. 
(7) Centrifuge for 15 minutes at 3000 x g. 
(8) Decant the supernatant, retaining the precipitate for 
counting. 
(9) Count each tube for one minute. 
Calculations ofResults 
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To calculate ferritin concentrations from a logit-log representation of the calibration 
curve, first calculate for each pair of tubes the average NSB-corrected counts per minute: 
Net Counts= Average CPM minus Average NSB CPM 
Then determine the binding of each pair of tubes as a percent of maximum binding 
(MB), with the NSB-corrected counts of the A tubes taken as 100%: 
Percent Bound= Net Counts x 100 
Net MB Counts 
Plot the percent bound on the vertical axis against concentration on the horizontal 
axis for each of the calibrators B-G, and draw a straight line approximating the path of 
these six points. Ferritin concentrations for the unknowns may then be estimated from the 
line by interpolation. 
Precision and Sensitivity 
The Double Antibody Ferritin assay has a minimal detection limit of approximately 
6 ng/rnl. A study was performed to determine the normal levels of ferritin, and 33 ng/ml 
was the median value in 58 females. By observing 29 patients with iron-deficiency 
anemia, a ferritin range of undetectable to 15 ng/ml was determined with 79% below 10 
ng/ml. 
Reference 
Diagnostic Products Corporation. October 23, 1986. Double 
Antibody Ferritin instruction booklet. Los Angeles, CA 
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A:wendix L
Nutrient Content of the Life Cereal 
Table 5. Nutrient Content of the Life Cereal. Nutrient information provided in the 
amount of 100 grams, edible portion. Values obtained from Handbook 8-8 (1982). 
Nutrients J.lD.i1s mean Std. Error 
Proximate: 
Water g 4.5 0.052 
Food Energy kcals 369 . 
Crude Protein g 18.4 0.073 
Total Lipid g 1.9 0.109 
Total Carbohydrate g 71.6 
Crude Fiber g 1.3 0.030 
Dietary Fiber g 3.2 0.051 
Ash g 3.6 0.040 
Minerals: 
Calcium mg 350 . 9.746 
Iron mg 26.42 0.388 
Magnesium mg 32.0 
Phosphorus mg 540 . 4.769 
Potassium mg 447. 8.317 
Sodium mg 521. 10.40 
Zinc mg 3.3 0.560 
Copper mg 0.53 0.035 
Manganese mg 3.44 
Vitamins: 
Thiamin mg 2.17 0.044 
Riboflavin mg 2.27 0.061 
Niacin mg 26.44 0.471 
Pantothenic acid mg 1.11 0.030 
Folacin mcg 84.0 6.097 
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AppeodixM 
Experiment I. Part B: Individual Subject Data 
Table 6. Summary of results for each subject including individual information on age, 
height, weight, hematocrit, ferritin, serum iron levels and SEIA values from Experiment I, 
Part B. Treatment l=ground beef, 2=ferrous sulfate, 3=cereal, and 4= ground beef/cereal. 
SUB TRT AGE HT. WT. FERR HCT S Fe S Fe S Fe S Fe SEIA SEIA SEIA 
# # inch kg ng/ml % (0) (1) (2) (3) (lh) (1.5h) (2 h) 
1 1 28 64 63 9 41 156 161 168 172 6 15 21 
1 2 64 10 42 68 94 103 100 50 68 62 
1 3 64 1 39 95 96 102 104 1 10 12 
1 4 64 17 39 110 113 119 116 4 12 8 
2 1 22 65 54 8 40 73 74 81 2 51 15 
2 2 54 8 40 43 49 53 . 65 6 10 22 
2 3 54 6 42 102 103 105 104 2 6 4 
2 4 54 6 40 92 102 113 118 11 24 30 
3 1 20 63 50 39 45 89 95 95 100 6 6 11 
3 2 52 20 44 84 106 113 122 20 27 35 
3 3 52 32 41 88 77 77 86 -12 -12 -2 
3 4 52 19 42 90 77 78 90 -12 -13 0 
4 1 31 62 
4 2 54 7 41 106 148 147 142 42 41 36 
4 3 57 9 43 146 148 154 2 9 
4 4 
5 1 20 66 51 15 42 61 66 65 65 5 4 4 
5 2 52 11 43 72 93 106 20 32 
5 3 52 9 42 64 65 70 76 1 6 13 
5 4 51 17 42 70 67 71 78 -3 1 8 
6 1 20 68 56 30 37 100 113 118 119 26 36 38 
6 2 54 10 41 73 99 69 73 26 -4 0 
6 3 55 13 39 121 125 125 5 5 
6 4 56 1 40 111 96 92 93 -17 -22 -21 
7 1 19 66 56 1 43 105 111 113 7 9 
7 2 56 5 40 95 130 135 151 38 43 60 
7 3 57 1 42 62 83 76 78 42 28 32 
7 4 56 11 42 75 75 74 78 0 3 -1 
8 1 20 64 57 5 44 95 106 102 109 12 8 16 
8 2 57 6 44 80 113 112 114 34 33 35 
8 3 57 1 46 68 75 50 78 8 -19 22 
8 4 57 1 42 97 104 118 124 8 24 31 
9 1 20 68 59 28 38 60 72 78 77 9 17 10 
9 2 59 13 40 45 52 58 53 23 34 32 
9 3 59 25 38 60 64 56 5 -5 
9 4 59 21 40 62 53 53 57 -11 -11 -6 
10 1 21 61 51 16 39 102 104 115 109 2 14 8 
10 2 51 13 40 63 91 95 28 32 
10 3 51 14 39 145 144 146 -1 1 
10 4 51 11 40 59 66 69 74 8 11 16 
85 
Ta.bl~ 6. (continued). 
SUB TRT AGE HT. WT. FERR HCT S Fe S Fe S Fe S Fe SEIA SEIA SEIA 
# # inch kg ng/ml % (0) (1) (2) (3) (lh) (1.5h) (2 h) 
11 1 26 65 56 1 38 33 70 79 81 9 10 12 
11 2 56 1 38 76 83 84 86 41 51 53 
11 3 56 1 38 39 41 44 47 2 6 10 
11 4 56 1 39 51 48 83 52 -4 39 1 
Ap_pendix N 
Analysis of Variance Results for Experiment I 
Analysis of Variance to examine differences in SEIA( 1 h) treatment means. 
Source of Variance elf Mean Square 
Subjects 10 114.4 
Treatment 3 2537.9 
Error 28 82.4 
Total 41 
Estimated SEIA(l h) means (28 elf): 
Treatment 
Beef 
FeS04 
Cereal 
Beef/Cereal 
sample 
10 
11 
11 
10 
mean 
24.0 * 
29.8 * 
1.3 
-0.5 
F Ratio Sign. Level 
1.4 0.236 
30.8 0.000 
std. dev of mean 
2 . .9 
2.7 
2.7 
2.9 
*Treatment means significantly higher than others. 
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Analysis of Variance to examine differences for SEIA(l.5 h) treatment means for all 
subjects. 
Source of Variance elf Mean Square 
Subjects 10 178.7 
Treatment 3 3703.0 
Error 27 208.0 
Total 40 
Estimated SEIA(l.5 h) means (28 elf) 
Treatment 
Beef 
FeS04 
Cereal 
Beef/Cereal 
sample 
9 
11 
11 
10 
mean 
37.6 * 
33.4 * 
0.9 
4.0 
F Ratio 
0.9 
17.8 
Sign. Level 
0.580 
0.000 
std. dev. of mean 
5.0 
4.3 
4.3 
4.7 
*Treatment means significantly higher than others. 
Analysis of Variance to examine differences between treatment means for SEIA(2 h). 
Source of Variance df Mean Square FRatio Sign. Level 
Subjects 10 179.6 .8 0.667 
Treatment 3 3806.2 16.0 0.000 
Error 21 237.5 
Total 34 
Estimated SEIA(2 h) means (28 df) 
Treatment sample mean std. dev. of mean 
Beef 
FeS04 
Cereal 
Beef/Cereal 
10 
11 
11 
10 
43.8 * 5.4 
37.0 * 5.3 
1.0 6.3 
4.3 5.1 
*Treatment means significantly higher than others. 
Analysis of Variance to examine differences between treatment means SEIA(max). 
Source of Variance df Mean Square FRatio Sign. Level 
Subjects 10 127.7 .8 0.591 
Treatment 3 5293.0 35.0 0.000 
Error 28 151.0 
Total 41 
Estimated SEIA(max) means (28 df) 
Treatment sample mean std. dev. of mean 
Beef 
FeS04 
Cereal 
Beef/Cereal 
10 
11 
11 
10 
45.8 * 
39.9 * 
3.4 
4.9 
*Treatment means significantly higher than others. 
4.0 
3.7 
3.7 
4.0 
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Aweorux o
E,weriment II: Individual Subject Data 
Table 7. Summary of results for each subject including individual information on age, 
height, weight, hematocrit, ferritin, serum iron levels and SEIA values from Experiment II. 
Treatment 1 = iron and ascorbic acid pre-trial supplements, treatment 2 = iron pre-trial 
supplements, treatment 3= ascorbic acid pre-trial supplements and treatment 4 = placebo 
pre-trial supplements. 
SUBJ 1RT AGE HT. WT. FERR HCT S Fe S Fe S Fe SEIA SEIA 
# # inch kg nglml % (0) (1) (2) (lh) (2h) 
1 1 21 67 63.2 0 43.5 63 52.5 -9 
2 61.8 0 40 46 99 115 45 58 
3 61.4 0 41.5 92 181 161 76 59 
4 61.8 0 41 79 95 115 14 30 
2 1 21 69 63.2 8 42 97 92 -4 
2 63.2 10 44 147 173 22 
3 63.2 8 43 76 98.5 20 
4 63.2 19 46 71 79 79 7 7 
3 1 27 67 61.8 0 38 27 61 28 
2 59.1 0 38.5 17 48 68 26 42 
3 58.2 10 47 34 34 36 0 0 
4 60 0 36 30 44 36 11 5 
4 1 18 64.5 51.8 23 45 38 29 33 -8 -4 
2 50.9 21 44 62 71 71 8 8 
3 51.8 18 47 33 29 38 -3 4 
4 50.9 16 43 44 50 55 5 9 
5 1 18 66.5 63.4 25 44 104 99 95 -4 -8 
2 63.2 40 45 105 144 124 34 16 
3 63.2 36 46 164 190 150 -12 36 
4 63.9 50 43 60 79 16 
6 1 21 66 49.1 3 45 17 17 0 
2 49.1 8 46 138 138 0 
3 49.1 7 44 270 241 -25 
4 49.5 3 46 195 187 -7 
7 1 20 65 55.5 32 43 133 144 155 9 19 
2 55.5 35 41 206 208 2 
3 55.9 30 44 157 111 100 -40 -49 
4 55.9 32 43 148 159 209 9 52 
8 1 30 67 55.9 0 37 216 216 219 0 2 
2 55.5 0 46 57 58 81 0 21 
3 54.1 0 43 34 73 80.5 33 40 
4 55.0 0 37 41 81 88 33 38 
9 1 19 65 56.4 103 38 85 92 96 6 9 
2 56.4 65 38.5 161 161 92 0 -57 
3 56.6 70 44 70 91 78 18 7 
4 55.7 85 42 217 233 264 40 85 
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Iabl~ 1. (continued). 
SUBJ 1RT AGE HT. WT. FERR HCT S Fe S Fe S Fe SEIA SEIA 
# # inch kg nglml % (0) (1) (2) (lb) (2h) 
10 1 23 64.5 52.5 9 43 155 162 155 6 0 
2 51.6 18 43 121 107 108 -12 -11 
3 52.5 11 43 80 87 90 6 9 
4 52.3 16 42 182 218 216 31 29 
11 1 21 63.5 56.8 9 45 120 142 19 
3 56.8 9 40 84 108 20 
12 1 20 63.5 58.2 12 40 35 36.5 80 1 39 
2 58.6 39 39 10 23 29 11 16 
3 58.2 20 38 48 43 -4 
4 58.2 16 40.5 34 46 50 10 13 
13 1 28 68.4 62.0 20 42 90 103 89 11 -1 
2 63.2 21 40 139 136 155 -3 13 
3 63.2 30 41 103 109 84.5 5 -16 
4 63.6 32 42 119 125 76 5 -37 
14 1 18 64 53.6 20 42 113 104 141 -8 24 
2 54.0 19 42 149 179 202 26 45 
3 54.0 10 40 174 187 181 11 6 
4 53.6 10 40.5 143 215 250 61 90 
15 1 33 67 61.6 0 45 115 135 138 17 20 
2 61.6 0 46.5 139 148 169 8 26 
3 61.6 2 46 125 222 156 84 30 
4 61.6 0 46 149 148 148 -1 -1 
16 1 23 70 67.3 22 43 113 111 138 -2 21 
2 65.9 20 43 99 146 135 31 20 
3 67.3 21 43 105 95 125 -9 17 
4 66.4 20 39 142 212 189 58 39 
17 1 19 64.7 57.0 16 46 71 88 90.5 15 17 
2 57 23 45 17 20 37 3 17 
3 57.0 21 42 39 54 55 13 14 
4 57.3 18 43 32 27 31 -4 -1 
18 1 24 61 45.5 49 45 234 243 235 8 1 
2 46.4 50 42 212 213 201 1 -9 
3 45.9 45 44 170 172 205 2 30 
4 45.0 52 46 135 147.5 138 11 3 
19 1 27 63 52.3 8 47 83 156 103 17 8 
2 52.7 9 42 45 46 1 
3 51.8 1 43 75 90 77 13 2 
4 51.2 4 44 38 47 55 8 15 
20 1 18 63 52.3 15 45 57 54 73 -3 14 
2 51.8 19 43 91 62 37 -25 -46 
3 52.3 16 42.5 20 40 39 34 33 
4 53.2 30 44.5 123 120 105 -3 -9 
21 1 30 63 51.4 0 38 335 364 346 24 9 
2 51.4 2 40 93 44 94 -41 1 
3 50.9 2 39 173 224 265 42 77 
4 51.4 0 37.5 102 148 151 38 40 
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Ta!.21~ 1. (continu ed). 
SUBJ TRT AGE HT. WT. FERR HCT S Fe S Fe S Fe SEIA SEIA 
# # inch kg ng/ml % (0) (1) (2) (lh) (2h) 
22 1 21 66 63.6 0 38 30 46 73 13 35 
2 63.2 0 41 54 72 15 
3 65.0 0 40 28 56 70 24 35 
4 63.2 0 38 52 84 71 26 16 
23 1 19 68 65 12 43 68 82 85 12 15 
2 66.4 25 46 90 93.5 3 
3 64.5 29 43 143 148 5 
4 64 19 43 89 93.5 98 4 8 
24 1 21 67 75.5 18 41 108 108 99 0 
2 75.9 8 41 71 44 64 -23 
3 74.3 13 42 69 78 78 8 8 
4 75.5 30 43 77 104 116 23 33 
25 1 22 69.6 66.2 8 45 92 134 148 36 49 
2 65.9 2 44 84 14 121 26 32 
3 65.9 7 46 44 108 98 56 47 
4 65.9 7 43.5 97 97 179 0 71 
26 1 35 62 52.3 4 42 113 160 40 
2 52.9 7 39 66 77 9 
3 52.0 10 37.5 65 153 72 
4 52.3 2 42 105 175 60 
27 1 18 66 59.3 10 43 34 85 114 44 69 
2 59.0 7 43.5 108 61 64 -40 -38 
3 60.5 5 44 88 113 116 22 24 
4 61.0 6 42.5 108 105 98 -3 -9 
28 1 18 68 59.6 6 42 158 190 27 
2 59.0 5 40 184 210 22 
3 59.5 7 45 46 56 9 
4 59.0 20 44 105 111 118 5 11 
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Appendix P
Analysis of Variance Results for Experiment II
SEIA(l h). Analysis of Covariance to examine differences between treatments for subjects 
for SEIA(l h). Subjects with 1.5 hour data are not included. 
Source of Variance df Mean Square F Ratio Sign. Level 
Ferri tin 1 1753.8 0.5 0.651 
Order 3 236.5 3.3 0.073 
Subjects 23 427.4 0 .8 0.705 
Order{freatment 9 286.6 1.5 0.836 
Treatment 3 789.2 0.5 0.225 
Error 57 527.2 
Total 96 
Estimated SEIA(l h) treatment means (55 df): 
Treatment sample mean std. dev. 
Iron/ Ase Acid 25 9.8 4.9 
Iron/No Ase Acid 25 5.6 4.7 
No Iron/ Ase Acid 23 18.3 5.0 
No Iron/No Ase Acid 24 16.2 4.9 
SEIA(2 h) Analysis of variance to examine differences between treatments means for all 
subjects for SEIA (2 h). This analysis also includes subjects with blood draws at 1.5 hour. 
Source of Variance df Mean Square F Ratio Sign. Level 
Ferri tin 1 46.4 0.08 0.168 
Order 3 1309.2 1.83 0.168 
Subjects 24 714.4 0.88 0.231 
Order{freatment 9 460.8 0.76 0.605 
Treatment 3 535.6 0.89 0.424 
Error 58 565.6 
Total 98 
SEIA(2 h) Treatment Means (58 elf): 
Treatment sample 
Iron/ Ase Acid 25 
Iron/No Ase Acid 20 
No Iron/ Ase Acid 27 
No Iron/No Ase Acid 27 
SEIA(2 h) Order Means (24 elf): 
Order sample 
1,2,3,4 27 
2,3,4,1 25 
3,4,1,2 23 
4,1,2,3 * 24 
mean 
16.3 
8.2 
17.4 
20.2 
mean 
10.2 
10.0 
10.7 
31.2 
std. dev. 
4.9 
5.7 
4.6 
4.7 
std. dev. 
5.4 
5.7 
7.2 
7.8 
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* Subjects in this group had a mean ferritin level of 9.9 ng/ml, vs. order group 3412 which 
had a mean ferritin level of 24.4 ng/ml. 
Maximal Absorption. Analysis of variance to examine differences for SEIA(max) means 
between treatments for all subjects. This analysis includes all subjects. 
Source of Variance df Mean Square FRatio Sign. Level 
Order 3 970.7 1.29 0.299 
Subjects 24 749.9 1.39 0.143 
Order!freatment 9 261.2 0.49 0.880 
Treatment 3 750.4 1.39 0.252 
Error 65 538.3 
Total 109 
SEIA(max) Treatment Means (65 elf): 
Treatment sample mean std. dev. 
Iron/ Ase Acid 28 19.0 4.4 
Iron/No Ase Acid 27 12.3 4.5 
No Iron/ Ase Acid 28 22.4 4.4 
No Iron/No Ase Acid 27 24.3 4.5 
SEIA(max) Order Means (24 df): 
Order 
1,2,3,4 
2,3,4,1 
3,4,1,2 
4,1,2,3 * 
sample 
28 
28 
24 
30 
mean 
16.5 
15.3 
17.4 
28.9 
std. dev. 
5.2 
5.2 
5.6 
5.2 
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* Subjects in this group had a mean ferritin level of 9.9 ng/ml, vs. order group 3412 which 
had a mean ferritin level of 24.4 ng/ml. 
Ferritin. Analysis of variance to examine differences in serum ferritin levels due to the 
order grouping, diet or treatments. 
Source of Variance df Mean Square F Ratio 
Protein 1 165.0 6.07 
Iron 1 113.6 4.18 
Order 3 294.1 0.23 
Subjects 24 1249.0 10.82 
Treatment 3 50.9 1.87 
Order{freatment 9 92.9 3.41 
Error 68 27.2 
Total 109 
Estimated Order Group Means for Ferritin (24 df) 
Order 
1,2,3,4 
2,3,4,1 
3,4,1,2 
4,1,2,3 
sample 
28 
28 
24 
30 
mean 
16.3 
16.7 
24.4 
9.9 
Sign. Level 
std. dev. 
6.7 
6.7 
7.8 
7.1 
0.016 * 
0.045 * 
0.871 
0.000 * 
0.143 
0.002 * 
SEIA{max) Differences in Low vs. Hi~h Ferritin Subjects 
Low Ferritin Subjects. Analysis of variance to examine mean differences for SEIA(max) 
between treatments for subjects (n=18) with low serum ferritin (<19 ng/ml). This analysis 
does not take into account that repeated measurements are made on the same subject. 
Source of Variance df 
Treatment 
Error 
Total 
3 
65 
68 
Mean Square F Ratio 
3119.5 
1335.2 
2.3 
Sign. Level 
0.082 
SEIA(rnax) means (65 df): 
Treatment sample mean std. dev. 
Iron I Ase Acid 17 33.2 8.8 
Iron I No Ase Acid 17 13.8 8.8 
No Iron I Ase Acid 18 45.8 8.6 
No Iron I No Ase Acid 17 26.3 8.8 
Hi~h Ferritin Effect. Analysis of Variance to examine mean differences for SEIA(max) 
between treatments for subjects (n=lO) with high serum ferritin (>20 ng/ml}. This 
analysis does not take into account that repeated measurements are made on the same 
subject. 
Source of Variance df 
Treatment 
Error 
Total 
3 
35 
39 
Mean Square F Ratio 
469.4 
646.9 
0.73 
SEIA(max) means for high ferritin subjects (39 df): 
Treatment 
Iron I Ase Acid 
Iron I No Ase Acid 
No Iron I Ase Acid 
No Iron I No Ase Acid 
sample 
10 
10 
10 
10 
mean 
4.8 
9.9 
10.4 
21.1 
SEIACmax) Combined Iron Treatment Differences 
in All, Low and Hi~h Ferritin Subjects 
Sign. Level 
0.54 
std. dev. 
8.0 
8.0 
8.0 
8.0 
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Iron Effects:All Subjects. Analysis of Variance to examine mean differences for 
SEIA(max) between combined treatments for all subjects (n=28). The two combined 
treatments that had iron (1 +2) vs. two without (3+4). This analysis talces into account that 
repeated measurements are made on the same subject. 
Source of Variance df Mean Square F Ratio Sign. Level 
Order 3 1018.0 1.4 0.279 
Subject 24 748.2 1.5 0.104 
Treatment 1 1823.4 2.8 0.081 
Order{freatment 3 297.7 0.6 0.627 
Error 78 508.8 
Total 109 
SEIA(max) treatment means (78 df): 
Combined Treatment 
Iron (1+2) 
No Iron (3+4) 
sample 
55 
55 
mean 
15.8 
23.4 
std. dev 
3.1 
3.1 
95 
Iron Effects:Low Ferritin Subjects. Analysis of Variance to examine mean differences for 
SEIA(max) between combined treatments for subjects (n=18) with low serum ferritin (<19 
ng/ml). The two combined treatments two that had iron (1 +2) vs. two without (3+4). 
This analysis does not take into account that repeated measurements are made on the same 
subject. 
Source of Variance df Mean Square F Ratio Sign. Level 
Ferri tin 1 3102.3 4.8 * 0.032 
Treatment 1 1823.4 2.8 0.099 
Error 71 650.9 
Total 73 
SEIA(max) treatment means (34 df) : 
Combined Treatment sample 
Iron (1+2) 
No Iron (3+4) 
37 
37 
mean 
17.7 
27.7 
std. dev 
4.2 
4.2 
Iron Effects: Hi~h Ferritin. Analysis of variance to examine niean differences for 
SEIA(max) between combined iron treatments for subjects with high serum ferritin (>20 
ng/ml). The two combined treatments include both that had iron (1 +2) vs. those without 
(3+4). This analysis does not take into account that repeated measurements are made on 
the same subject 
Source of Variance df 
Treatment 
Error 
Total 
3 
35 
38 
Mean Square F Ratio 
49.9 
345.6 
0.14 
Sign. Level 
0.71 
SEIA(max) treatment means (38 elf): 
Treatment 
Iron (1+2) 
No Iron (3+4) 
sample 
19 
18 
mean 
13.8 
16.2 
std. dev. 
4.3 
4.4 
96 
Ascorbic Acid Effects: All Subjects. Analysis of variance to examine mean differences for 
SEIA(max) between combined treatments for all subjects (n=28). The two combined 
treatments that had ascorbic acid (1 +3) vs. the two without (2+4). This analysis takes into 
account that repeated measurements are made on the same subject. 
Source of Variance df Mean Square 
Order 3 970.7 
Subject 24 749.9 
Treatment 1 153.9 
Order(f reatment 3 41.0 
Error 78 537.4 
Total 109 
SEIA(max) treatment means (78 elf): 
Combined Treatment 
Ascorbic Acid (1 +2) 
No Ascorbic Acid (3+4) 
sample 
56 
54 
FRatio 
1.3 
1.4 
0.3 
0.07 
mean 
20.7 
18.3 
Sign. Level 
0.299 
0.138 
0.594 
0.973 
std. dev 
3.1 
3.2 
Ascorbic Acid Effects; Low Ferritin Group. Analysis of Variance to examine mean 
differences for SEIA(max) between combined treatments for subjects (n= 18) with low 
serum ferritin ( <19 ng/ml). The two combined treatments include any that had ascorbic 
acid (1 +3) vs. those without (2+4). This analysis does not take into account that repeated 
measurements are made on the same subject Ferritin is used as a covariate. 
Source of Variance df Mean Square F Ratio Sign. Level 
Ferri tin 1 2873.4 4.34 0.041 
Treatment 1 1092.6 1.65 0.203 
Error 71 661.2 
Total 73 
SEIA(max) treatment means (71 elf): 
Combined Treatment 
Ascorbic Acid (1 +2) 
No Ascorbic Acid (3+4) 
sample 
39 
35 
mean 
26.3 
18.7 
std. dev 
4.1 
4.3 
97 
Ascorbic Acid Effects: Hi~h Ferritin Group. Analysis of Variance to examine mean 
differences for SEIA(max) between combined treatments for subjects with high serum 
ferritin (>20 ng/ml). The two combined treatments include any that had iron (1 +2) vs. 
those without (3+4). This analysis does not take into account that repeated measurements 
are made on the same subject 
Source of Variance df Mean Square F Ratio Sign. Level 
Treatment 
Error 
Total 
1 
35 
36 
1144.3 
314.4 
SEIA(max) treatment means (35 elf): 
Treatment 
Ascorbic Acid (1+3) 
No Ascorbic Acid (2+4) 
sample 
17 
20 
3.64 
mean 
8.9 
20.1 
0.065 
std. dev 
4.3 
4.0 
